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“We'll go because it's Thursday, and we'll go to wish everybody a Very Happy Thursday.” 
 
Winnie-the-Pooh 
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ABSTRACT 
The overall aims of this thesis were to elucidate the circulatory responses to ultra-endurance exercise 
(Adventure Racing), and furthermore, to contribute to the clarification of the so called “exercise-induced 
cardiac fatigue” in relation to said exercise. 
An Adventure race (AR) varies in duration from six hours to over six days, in which the 
participants have to navigate through a number of check-points over a pre-set course, using a combination 
of three or more endurance/outdoor sports, e.g., cycling, running, and kayaking. This thesis is based on 
the results from four different protocols; 12- and 24-h (n = 8 and 9, respectively) in a controlled setting 
with fixed exercise intensity, and 53-h and 5-7-day (n = 15 in each) in field setting under race conditions. 
The subjects in all protocols were experienced adventure racing athletes, competitive at elite level. Study 
I and II address the circulatory responses and cardiovascular drift, using methods for monitoring heart 
rate (HR), oxygen uptake (VO2), cardiac output (non-invasive re-breathing) and blood pressure, during 
ergometer cycling at fixed steady state work rate at periods before, during and after the ultra-endurance 
exercise. In Study III and IV we examined the possible presence of exercise-induced cardiac fatigue after 
a 5-7-day AR, from two different perspectives. In Study III analyses were performed with biochemical 
methods to determine circulating levels of cardiac specific biomarkers (i.e., creatine kinase isoenzyme 
MB (CK-MB), troponin I, B-type natriuretic peptide (BNP) and N-terminal prohormonal B-type 
natriuretic peptide (NT-proBNP)). We also made an attempt to relate increases in biomarkers to rated 
relative performance. In Study IV we used tissue velocity imaging (TVI) (VIVID I, GE VingMed 
Ultrasound, Norway) to determine whether the high workload (extreme duration) would induce signs of 
functional cardiac fatigue similar to those that occur in skeletal muscle, i.e., decreased peak systolic 
velocities. Using conventional echocardiography we also evaluated whether the hearts of experienced 
ultra-endurance athletes are larger than the normal upper limit.  
The central circulation changed in several steps in response to ultra-endurance exercise. Compared 
to initial levels, VO2 was increased at every time-point measured. The increase was attributed to 
peripheral adaptations, confirmed by a close correlation between change in VO2 and change in arterio-
venous oxygen difference. The first step of the circulatory response was typical of normal (early) 
cardiovascular drift, with increased HR and concomitantly decreased stroke volume (SV) and oxygen 
pulse (VO2/HR), occurring over the first 4-6 h. The second step, which continued until approximately 
12h, included reversed HR-drift, with normalisation of SV and VO2/HR. When exercise continued for 50 
h a late cardiovascular drift was noted, characterised by increased VO2/HR, (indicating more efficient 
energy distribution), decreased peripheral resistance, increased SV, and decreased work of the heart. 
Since cardiac output was maintained at all-time points we interpret the changes as physiologically 
appropriate adaptations.  
Our findings in Study III point towards a distinction between the clinical/pathological and the 
physiological/exercise-induced release of cardiac biomarkers. The results imply that troponin and CK-
MB lack relevance in the (healthy) exercise setting, but that BNP, or NT-proBNP adjusted for exercise 
duration, might be a relevant indicator for impairment of exercise performance. High levels of NT-
proBNP, up to 2500 ng · l-1, can be present after ultra-endurance exercise in healthy athletes without any 
subjective signs or clinical symptoms of heart failure. However, these high levels of NT-proBNP seemed 
to be associated with decreased relative exercise performance, and might be an indicator of the cardiac 
fatigue that has previously been described after endurance exercise.  
Study IV revealed that the sizes of the hearts (left ventricle) of all of our ultra-endurance athletes 
were within normal limits. The measurements of peak systolic velocities showed (for group average) no 
signs of cardiac fatigue even after 6 days of continuous exercise. This discrepancy between ours and 
other studies, involving e.g., marathon or triathlon, might reflect the fact that this type of exercise is 
performed at relatively low average intensity, suggesting that the intensity, rather than the duration, of 
exercise is the primary determinant of cardiac fatigue. 
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1 INTRODUCTION 
 
1.1 HISTORICAL ASPECTS OF ULTRA-ENDURANCE EXERCISE 
The first thing that comes to peoples mind when you talk about endurance exercise is most often 
marathon running. The marathon allegedly dates back to ancient Greece where the messenger 
Pheidippides ran the approximately 40 km from the battlefield back to the capital Athens. He 
overcame the extreme physiological strain, delivered the good news of victory and when fell 
dead to the ground. However, in the eye of ultra-
endurance exercise the marathon is a super-sprint! 
 
Yet, ultra-endurance exercise is definitely not a 
new phenomenon. In 1762 Tomas Hauge sat the 
world record when he ran 100 miles in 23 h 15 
min. A century later, pedestrianism (i.e., endurance 
walking) had become popular. The longest races 
possible were 6-day races, that is, without 
competing on Sunday. The American Edward 
Payson Weston had a long-lasting professional 
walking career, holding numerous records for long-
distance endurance events. For example, in 1879 he 
defeated the British champion "Blower" Brown, in 
a 550 mile (890 km) match that he completed in the 
impressive time 141 hours 44 minutes (less than 6 days)! 
 
Still, people are always looking for new challenges. At the same rate as humans try to push 
boundaries and break the barriers of what the organism is capable of, new sports are created. 
One of these new extreme sports is adventure racing. This type of competitions first occurred 
in New Zealand in the 1980s as a combination of transferring Ironman Triathlon into the wild 
and away from strict courses, and to perform demanding expeditions in the form of a race. The 
Alpine Ironman, held in 1980, has been considered as the first adventure race (AR). 
Competitors ran, kayaked and skied individually for three days. A couple of years later, the 
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first edition of the now famous Coast to Coast race was held (243 km; 151 miles). In this race 
skiing was exchanged for cycling, setting the standard for which disciplines mostly involved 
in the modern adventure racing: trail running, cycling and paddling. Independently, a North 
American race, the Alaska Mountain Wilderness Classic debuted in 1982 and involved six 
days of unsupported wilderness racing (250-400 km; 150-250 miles). The race is still annual 
and the rules are simple: start to finish with no outside support, requiring that racers carry all 
food and equipment. In 1989, the modern era of adventure racing had clearly arrived with the 
launch of the Raid Gauloises. This race contained all the modern elements of adventure racing, 
including mixed-gender teams competing in a multi-day 400+ mile race. Over the years 
adventure racing has grown larger and spread all over the world. The major international 
competitions are becoming more and more prestigious and the financial incentives involved 
have substantially increased. The requirement for scientific structure for preparation and 
execution of the races naturally rises to the same degree. 
 
1.1.1 Adventure racing  
The modern adventure racing is an ultra-endurance sport, in which a pre-set course is covered in 
the shortest possible time using a combination of three or more endurance/outdoor sports, e.g., 
cycling, running, kayaking and other exercise modes. Other exercise modes that can be included 
are for example in-line skating, canyoneering, mountaineering, river rafting, cross-country 
skiing and they vary with the location of the race and the time of year. The duration of an AR 
varies from six hours to over six days depending on the type of competition. During these 
competitions participants have to navigate, through a number of check-points, from start to 
finish. A team normally consists of three males and one female, or four males. The teams must 
stay close together for the entire course. Each team member has to carry a backpack with 
compulsory gear, weighing approximately 5-10 kg. The races are most often of non-stop-
character and it is at each team’s discretion to decide when, and how much, to eat, rest and sleep, 
while the race clock keeps going. Teams arrange their own food, but can be allowed to receive 
assistance from a support team at transition areas (where athletes change exercise modes) 
approximately every 6-24 h. The races are held in a variety of weather and harsh environments 
where the team’s speed is dictated by its weakest team member. To complete the race as fast as 
possible the athletes within the team help each other, e.g., stronger racers carry more of the food 
and equipment and/or take a weaker team member in tow (i.e., a faster runner tows a slower 
runner with an elastic cord attached between their waists). A race strategy that actually has been 
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scientifically evaluated with the conclusion that towing improved overall running performance 
considerably (Grabowski and Kram, 2008). 
 
Thus, an AR varies in form and duration, but is no matter the nature of the specific competition 
still in many aspects an extreme sport, compared with more traditional endurance events. AR 
puts extreme physical and psychological demands on the participants due to its extreme duration 
and non-stop nature. The adventure racing athlete does not need to perform high maximum 
speed in each discipline, although this can occur. Instead, the demands of both endurance and 
technique are extremely high. Furthermore, we have estimated the total energy expenditure for a 
24-h race for a fit male adventure racer to approximately 18-20 000 kcal, which is almost 10 
times more than normal basal metabolism (Enqvist et al., 2010). The effect of sleep deprivation 
on both mental and physiological functions during the races must be included in the total 
complex of problems during these extreme exercise durations. This makes the adventure racer to 
an extreme version concerning human performance, and from a human biological point of view 
the sport becomes very attractive to investigate. In consequence, the physiological adaptation to 
ultra-endurance exercise is versatile, with interesting research questions concerning for example 
energy balance, dietary intake and its consequences for choice of energy substrate during 
exercise, blood lipid changes, circulatory and muscular adaptations, hormonal status, 
immunological response, etc.  
 
1.2 THE PROJECT “PHYSIOLOGY OF ADVENTURE RACING” 
The project “Physiology of Adventure Racing” was initiated in the spring of 2005 in a 
collaboration between Karolinska Institutet and The Swedish School of Sport and Health 
Sciences. Empirical observations claimed that athletes who have been engaged in this type of 
sport for several years have a large advantage compared to novices in the sport. It depends of 
course in part on the fact that they are more experienced, but even athletes from traditional 
endurance sports with a documented higher aerobic capacity (i.e., higher VO2max) have 
difficulties to keep up with ultra-endurance specialists when exercise duration exceeds three or 
four hours. The research group was assembled with a combination of students that knew the 
sport and its problems (among others, the author of this thesis) and skilled experienced 
researchers. The initial approach was very broad and based on the vague hypothesis that the 
successful AR-athletes differed physiologically in some way from successful athletes in other 
(more traditional) endurance sports. In order to address as many aspects as possible and still 
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maintain a high scientific level several other research groups were invited to take part in the 
protocols and perform investigations in their field of specialty. So far, in addition to the four 
papers in this thesis, six papers have been published (Related papers 1-6, i.e., Fernström et al., 
2007; Berg et al., 2008; Sahlin et al., 2010; Enqvist et al., 2010; Wallberg et al., in press; 
Wichardt et al., in press) three are in manuscript (Related papers 7-9, i.e., Borgenvik et al., 
submitted; Mattsson et al., submitted manuscript; Mattsson et al., in manuscript) and a handful 
more are under preparation. 
 
 
1.3 PREVIOUS RESEARCH ON ADVENTURE RACING  
Since AR is a relatively new and rather small sport the scientific grounds surrounding it are still 
very limited. Like the main part of investigations on other ultra-endurance events the articles 
on AR are almost always based on data collected before and after the race. Measurements at 
any points during the exercise itself are non-existent. Another aggravating factor for this type of 
research is that normally there is no possibility to reliably standardise parameters such as work 
load, rest, sleep and diet during competition-based investigations. 
 
When our project started in 2005, less than fifteen peer-reviewed studies could be found, and all 
of them were concerning medical aspects as injuries and infectious diseases. Fortunately, during 
the last five-six years a few other research groups have added information to the scientific 
knowledge base within this area. I will in the following paragraphs mention some key 
investigations concerning AR that have been conducted and published up till now (February, 
2011). 
 
1.3.1 Outbreak of infectious diseases 
Several outbreaks of infectious diseases have been reported in conjunction with ARs. The first 
one was 13 cases of African tick-bite fever, caused by Rickettsia africae, in competitors after an 
AR in South Africa (Fournier et al., 1998). Other examples are outbreaks of leptospirosis 
following an "extreme-adventure" athletic event on the island of Guam (Haddock et al., 2002), 
during the race Eco-Challenge in Malaysia 2000 (Sejvar et al., 2003) and among participants in 
an AR in Florida, USA 2005 (Stern et al., 2010). 
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1.3.2 Injuries 
Several studies have addressed the question of injuries during this extreme sport. In the 
beginning Kohler (2003) discussed the risk for injuries and the role of the sports chiropractor. 
Greenland (2004) also wrote an article along the same line of thought discussing the new roles 
of the medical staff involved in this type of races. After that, epidemiological studies of the 
injury spectra in AR athletes have been conducted. Fordham and co-workers (2004) studied the 
impact of the demographics and training characteristics of AR athletes on injury location and 
characteristics. The same year did Talbot and colleagues (2004) report that the prevalence of 
altitude illness was over 14% during the Primal Quest 2002 (a four-or-more-days non-stop race). 
During the same race the incidence and type of injury and illness occurring during an AR was 
examined, specifically identifying those resulting in withdrawal from the event (Townes et al., 
2004). A similar study was also performed during the same race the following year 
(McLaughlin, 2006) reporting a comparable incidence of patient encounters with a high 
frequency of minor skin and soft tissue injuries, especially blisters. During the expedition-length 
(i.e., >36 h) race Southern Traverse 2003 as many as 38 out of 48 investigated racers (79%) had 
musculoskeletal injuries after the race. All of the racers experienced pain during or after the race 
(Anglem et al., 2008). To conclude, musculoskeletal injury and complaint during ARs is 
commonly reported (Townes et al., 2004; Anglem et al., 2008; Newham-West et al., 2010; 
Wichardt et al., in press).  
 
1.3.3 Exercise intensity and energy expenditure 
Beside medical considerations exercise intensity and energy expenditure has been a subject of 
investigation. Ashley and colleagues (2006) reported that HR averaged >100 beats • min-1 in a 
competitor who finished a 300 km course in approximately 100 h. Helge and co-workers (2007) 
reported a heart rate (HR) of 80% of HR-reserve (peak – rest HR, i.e., similar to exercise 
intensity measured as % of VO2max) in the beginning of a race, which was reduced to about 40% 
of HR-reserve after 15 h and remained on a similar level for the rest of the 115 h of racing. The 
same relative intensity and the decrease in intensity over time have later been verified (Lucas et 
al., 2008; Enqvist et al., 2010). Typically, the exercise intensity during an expedition-length AR 
is >60% of HR-reserve during the first 12 h and progressively fall to approximately 40% of the 
HR-reserve at 24 h and remain at that level for the rest of the race. Concerning nutrition and 
energy turn-over Zimberg and co-workers (2008) estimated an energy expenditure (EE) of 
24 500 kcal (≈ 365 kcal • h-1) and an energy intake (EI) of 14 700 kcal during a simulated 67 h 
AR. It is difficult to eat and drink enough during an AR, indicating that the typical race 
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competitors are unable to consume enough calories to offset their energy use. Our research 
group has found higher EE, ≈ 750 kcal • h-1 during 24-h and ≈ 365 kcal • h-1 during a 5-7-day 
race (Enqvist et al., 2010), but the simple explanation for our higher values could be that our 
subjects had higher body mass (BM). It should be recognised that AR can generate a significant 
negative energy balance, and that the adventure racers often present an inadequate nutritional 
profile both during racing and training (Zalcman et al., 2007; Zimberg et al., 2008; Enqvist et al., 
2010).  
 
1.3.4 Other investigations 
The objective of the present thesis is circulatory response and cardiac fatigue. Unfortunately, the 
existing scientific knowledge is meager and only one study has examined how the heart is 
affected during AR (Ashley et al., 2006), which is discussed more thoroughly in the following 
sections. 
 
Apart from the papers listed above and our research group’s scientific contribution (Related 
papers), there are a couple of diverse investigations. Lucas et al. (2009) investigated cognitive 
function and strength capacity after the Southern Traverse 2003 and found that only complex 
decision making was impaired by the race, and that strength was only modestly impacted 
(<20%), at least relative to the extent of decrease in pace that occurs in these races. Levada-
Pires and colleagues (2010) examined the risk of post-exercise immunosuppression after the 
Ecomotion Pró 4-5-day race in Brazil, and they concluded that the race induced neutrophil and 
lymphocyte death. 
 
1.4 CIRCULATORY ADAPTATIONS  
1.4.1 Cardiovascular drift 
The central circulation changes during prolonged endurance exercise. The “cardiovascular drift” 
describes a number of well-established circulatory adaptations to prolonged endurance exercise 
at fixed work rate. Heart rate (HR) increases slowly during exercise at fixed work rate, with a 
concomitant decrease in stroke volume (SV) (Figure 1) (Åstrand et al., 1960; Ekelund, 1967; 
Saltin and Stenberg, 1964). In these articles the durations of exercise were six hours, three hours, 
and one hour, respectively. Even if physical training improves several circulatory parameters, for 
example increased maximal SV and decreased HR at a submaximal rate of work, the HR drift 
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with time remains (Ekblom, 1970). The cardiovascular drift is measurable already after 10 
minutes of moderate exercise in both neutral and warm environments (Ekelund, 1967). 
 
Figure 1: Circulatory adaptation to prolonged exercise at 75% of VO2 max. 
 
 
Lower part: Experimental procedure for the experimental day. The effective work 
time during the prolonged period was 180 min (rest pauses included, I95 min). 
Upper part: the percentual changes in heart rate, plasma proteins, arterio-venous 
oxygen difference, blood volume, body weight, mean arterial blood pressure and 
stroke volume during exercise. (Saltin & Stenberg, 1964) 
 
The decrease in SV during prolonged exercise is commonly suggested to be caused by a 
progressive increase in cutaneous blood flow (CBF) as core temperature rises, reducing central 
venous blood pressure and end-diastolic volume (Johnson and Rowell, 1975; Rowell, 1974). 
Consequently, dehydration during prolonged exercise also reduces total blood volume, which 
further contributes to the cardiovascular drift (Gonzàlez-Alonso et al., 1995; Saltin, 1964). 
However, the core temperature and the CBF remain stable after 20 min of exercise. It is 
therefore suggested that any further decline in SV is a consequence of an increase in HR (Coyle 
and Gonzàlez-Alonso, 2001; Fritzsche et al., 1999). This implies that the cardiovascular drift is 
initially driven by decreased SV but any change after approximately half an hour is instead 
driven by increased HR.  
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If this “classical” cardiovascular drift was to continuously progress during a 5-7-day AR it 
would implicate athletes with maximal HR when standing still. Since we know empirically that 
the participants are able to complete the races, and keeping a relatively high pace even during 
the later stages, this is highly unlikely. Some clarifying information was provided in an early 
study by Irma Åstrand (1960) where the subjects cycled and ran at fixed work rates 
corresponding to 50% of maximal oxygen uptake (VO2max) simulating a full physically 
demanding workday (7 bouts à 50 min during 8 h). HR increased on an average 11 beats • min-1 
from the first two to the last two bouts. This is a similar increase after approximately six hours of 
exercise as after the three hours in the study by Saltin and Stenberg (1964), which indicates that 
the drift does not have a continuous progression. However, the cardiovascular drift during the 
full duration of an AR is unknown. 
 
Besides the increase in HR, the oxygen uptake (VO2) at standardised submaximal work rate 
increased with on average 6% (0.09 l • min-1) in the study by Åstrand (1960). Saltin and 
Stenberg (1964) confirmed the magnitude, 5%, of the concomitant VO2 drift during 3 h 
exercise. The drift could be ascribed to decreased economy of movement, with general muscle 
fatigue leading to recruitment of alternative muscle fibres and agonist muscles (Dick and 
Cavanaugh, 1987; Westerlind et al., 1992). The increase in VO2 means that the work 
efficiency is decreased, and thus that more and more energy is required to maintain work rate 
or race pace. Since negative energy balance already is a problem for adventure racers the 
upward drift in VO2 is highly unwelcome, especially if the drift would continue along with 
exercise duration.   
 
Even though the increased VO2 may be concomitant with the changes in HR, these drifts are not 
necessarily of the same origin. 
 
1.5 CARDIAC DAMAGE AND “EXERCISE-INDUCED CARDIAC FATIGUE” 
The concept of exercise-induced cardiac fatigue was in modern time first proposed by Saltin and 
Stenberg in 1964 as an explanation for the reduced SV observed during prolonged exercise. 
However, the concept of cardiac fatigue is debated and so far there is no consensus. The general 
belief is that our hearts, if healthy, are unaffected by any exercise or strain we humans can 
expose it to, and that it simply continues to work until the day when it is all over. The major 
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obstacle to overcome is to find methods that actually can determine if there is such a thing as 
decreased cardiac capacity and performance. An overall hypothesis in Study III and IV was that 
cardiac muscle can be fatigued in the same way as skeletal muscle (Figure 2).  
 
Figure 2: Schematic model of signs and measurements of exercise-induced fatigue in 
skeletal and cardiac muscle. 
 
 
For investigations of skeletal muscle fatigue it is possible both to directly measure the maximal 
voluntary force and contraction velocity against external resistance, and to extract muscle 
biopsies and perform biochemical and microscopy analyses on the material. Unfortunately, these 
types of investigation are not available for evaluation of cardiac function in healthy humans. A 
remaining possibility, for both skeletal and cardiac muscle, is analyses of biomarkers in blood. 
Microscopy findings has proven damaged skeletal muscle cells after strenuous exercise, with a 
concurrent increase in plasma levels of biomarkers e.g., creatine kinase (CK). The isoenzyme 
CK-MB is expressed in cardiac muscle and has therefore been used extensively as an indication 
for myocardial damage in heart attacks. Even though other, more specific biomarkers (further 
discussed in section “1.5.1 Cardiac biomarkers”) has replaced CK-MB in the clinical setting we 
report three different biomarkers in Study III. All of these biomarkers are a sign of muscle cell 
degradation and damage. However, both concerning skeletal and cardiac muscle, the exercise 
induced elevation in biomarkers is rapidly reversed, i.e., within a few days. The same holds true 
for decrement maximal force and velocity of contraction in skeletal muscle. In a related manner, 
the measurable decrease in capacity and performance in skeletal muscle returns to initial levels 
after a period of rest. Thus, we interpret all rapidly reversed exercise-induced signs of cardiac 
damage as cardiac fatigue, and, hence, the expression “cardiac fatigue” is used throughout this 
text.  
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1.5.1 Cardiac biomarkers 
Cardiac troponin T and I are considered to be highly sensitive and specific markers for detecting 
myocardial damage even in the presence of skeletal muscle injury. Several studies have 
demonstrated increases in troponin I or T after prolonged exercise, which would indicate that 
physical exertion may result in myocardial damage (Rifai et al., 1999; Neumayr et al., 2002; 
Scharhag et al., 2005; Neilan et al., 2006). A recent meta-analysis suggested that despite 
substantial methodological variation among studies, exercise-induced release of troponin T can 
be observed after exercise in almost half of the athletes participating in endurance exercise 
events (Shave et al., 2007). How these troponins are released is not entirely clear, but based on 
the transient nature of the increases, the mechanism has been hypothesised to be leakage of 
troponin from the cytosolic pool (Wu and Ford, 1999) due to membrane damage induced by 
oxidative stress or hypoxia (Michielsen et al., 2008). This notion is compatible with the 
increased production of reactive oxygen species in skeletal muscle that we have previously 
shown after 24-h of ultra-endurance exercise (Sahlin et al., 2010). 
 
In clinical medicine, natriuretic peptides, including B-type natriuretic peptide (BNP) and the 
more stable N-terminal prohormonal B-type natriuretic peptide (NT-proBNP), are used to detect 
increased myocardial wall tension in conditions such as heart failure. Tachycardia, arrhythmias 
and physical exercise may also increase these peptides. Increases in BNP have been shown in 
patients with left ventricular dysfunction and BNP levels correlate both with heart failure stage 
according to the New York Heart Association classification, and with prognosis of cardiac 
dysfunction (Wei et al., 1993; Yoshimura et al., 1993; Yasue et al., 1994; Omland et al., 1996; 
Clerico et al., 1998). The suggested optimal cut-off point for BNP for making the diagnosis of 
congestive heart failure is >100 ng · l-1, and the negative predictive value is <50 ng · l-1 (Maisel 
et al., 2002; 2004). The clinical reference value for NT-proBNP in healthy subjects is <100 ng · 
l-1; in clinical practice, values >300 ng · l-1 are strong indicators of heart failure and values >5000 
ng · l-1 are highly significant predictors of mortality within three months (Januzzi et al., 2005; 
Januzzi, 2006). The highest values of NT-proBNP previously reported in healthy athletes are 
approximately 600 ng · l-1 after a marathon (Niessner et al., 2003; Neilan et al., 2006) and after ≈ 
10 h of running (Neumayr et al., 2005). Outliers in a study examining marathon, 100-km 
running and MTB-marathon (cycling) reached approximately 900 ng · l-1 (Scharhag et al., 2005). 
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1.5.2 Cardiac function – Echocardiography   
Employing two-dimensional echocardiography left ventricular function at rest, in the form of 
e.g., decreased ejection fraction, has been shown to be reversibly impaired after marathon 
(George et al., 2004; Whyte et al., 2005; Middleton et al., 2007), ultra marathon (Niemelä et al., 
1984; 1987), Ironman triathlon (Douglas et al., 1987; 1990a; 1990b; 1998; Whyte et al., 2000), 
and adventure racing (Ashley et al., 2006) (Figure 3). After this type of triathlon a significant 
reduction in atrial function (reflected in the ratio of early [E] to late [A], filling; E/A) has also 
been detected (Shave et al., 2004).  
 
Although several other investigations have come to opposite conclusions, on the basis of their 
meta-analysis of findings on exercise for a maximum of 24 h Middleton and co-workers (2006) 
maintain that the ejection fraction and systolic blood pressure/end-systolic volume are, indeed, 
attenuated, indicating impaired systolic function, in part due to altered cardiac loading. In 
addition, this same meta-analysis revealed impairment of left ventricular relaxation, manifested 
by a decrease in E/A, in this case unrelated to changes in loading. The only published study 
concerning the effects of exercise of extreme duration (an 84-110-hour race) found reduction in 
both systolic and diastolic left ventricular function at rest following this exercise, with decreases 
in fractional shortening, ejection fraction and E/A (Ashley et al., 2006) (Figure 3). 
 
Figure 3: Changes in fractional shortening. 
 
  
 
Decline in fractional shortening plotted against length of race as reported for key 
studies. In the current study, the exercise challenge and drop in fractional 
shortening were greater than previously reported. FS = fractional shortening. 
(Ashley et al., 2006) 
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However, it should be noted that fractional shortening and ejection fraction does not give any 
information about SV, CO or if the heart is matching the metabolic demand. 
 
In their recent review, Oxborough and colleagues (2010) arrived at conclusions similar to those 
reached by Middleton and co-workers (2006). In addition, they proposed that modern ultrasound 
techniques, which provide a more complete assessment of cardiac mechanistic function, should 
be applied to clarify the phenomenon of exercise-induced cardiac fatigue in great detail.  
 
1.5.3 Cardiac function – Tissue velocity imaging 
Tissue velocity imaging (TVI), a well-established procedure for quantitative analysis of 
longitudinal myocardial velocities (Brodin, 2004), has been shown to be a powerful tool for 
quantifying regional ventricular function, and thereby a valuable aid in the diagnosis of patients 
with various types of heart disease (Palmes et al., 2000; Kiraly et al., 2003; Hayashi et al., 2006). 
By focusing on specific regions of interest (ROIs) in a sequence of TVI images, velocity 
parameters for both the left and right ventricles can be measured. The most clinically useful 
information obtained from such a myocardial velocity curve concerns the peak systolic velocity 
(PSV) and both maximal early (E’, occurring during early diastolic filling) and late diastolic (A’, 
occurring during atrial contraction) velocities. In addition to these main events of primary 
interest, information about the contractile and elastic function of the heart can be extracted from 
the periods of isovolumic contraction (IVC) and isovolumic relaxation (IVR), which contain 
short myocardial deformations involved in pre- and post-systolic reshaping of the ventricles 
(Edvardsen et al., 2002; Lind et al., 2004). One study involving assessment by colour TVI 
revealed that scarred segments of the myocardium in patients with coronary artery disease 
exhibit lower peak systolic velocities than the corresponding segments in healthy volunteers, 
both at rest and under stress, and, furthermore, that the ischemic segments demonstrate lower 
peak velocities and smaller increments in velocity (Pasquet et al., 1999). 
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2 AIMS 
 
The overall aims of this thesis were to elucidate the circulatory responses to ultra-endurance 
exercise (Adventure Racing), and furthermore, to contribute to the clarification of the so called 
“Exercise-induced cardiac fatigue” in relation to said exercise. 
More specifically, the main aim of each of the individual papers was:  
I. To investigate the cardiovascular response at constant work rate during 24 h ultra-
endurance exercise. 
 
II. To investigate the nature of the acute adaptation of the central circulation to ultra-
endurance exercise seen in paper I, including the relative contributions of changes in SV 
and arterio-venous oxygen difference (a-v O2 diff) to the increased oxygen pulse 
(VO2/HR), at different stages during prolonged endurance exercise. Furthermore, to relate 
our results to the work of the heart and the discussion of exercise-induced cardiac fatigue. 
 
III. To examine the levels of different cardiac biomarkers in response to ultra-endurance 
exercise, i.e., 5-7 days of almost non-stop exercise in a competition with mixed endurance 
exercise events, so called adventure racing. In addition, we make an attempt to relate 
increases in biomarkers to rated relative performance. 
 
IV. To determine whether a high workload (extreme duration) induces signs of cardiac fatigue 
similar to those that occur in skeletal muscle, i.e., decreased peak systolic velocities. A 
secondary aim was to evaluate whether the hearts of experienced ultra-endurance athletes 
are larger than the normal upper limit.  
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3 SUBJECTS AND METHODS 
The four studies included in this thesis are based on data from four different exercise protocols 
(Figure 4). Overall, results and conclusions concerning circulatory response are derived from 
Study I and II, and those concerning cardiac fatigue from Study III and IV. 
 
Figure 4: Schematic model of connections between exercise protocols, studies and 
primary area of research. 
 
3.1 SUBJECTS 
The sport of Adventure racing imposes incredibly diverse physiological strains on the human 
body, and the participants have to balance demands such as sufficient endogenous storage of fat 
and high ability to carry, against sustained ability to run and perform other body mass related 
tasks. It seems desirable to simultaneously have a low body mass for running, strong thighs for 
cycling, and a dominant upper body for kayaking. Based on our findings the adventure racers 
display a distinct profile, in both anthropometric and physiological aspects, which differs from 
the specialist athletes’ (i.e., marathon runners, cyclists and kayakers, respectively). The athletes 
are relatively alike concerning body size and aerobic capacity, despite major differences in the 
training regime, hours of exercise each week, and years of experience. Compared to other 
endurance athletes the typical adventure racer is rather large and overall well-trained. However, 
we cannot distinguish if the similarities are due to a selection of individuals pre-disposed and 
suitable for this type of sport, or if the training for the sport itself sculptures a specific type of 
athlete (Mattsson et al., submitted manuscript). 
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Generally, the characterised adventure racers have aerobic capacity (i.e., fractional utilisation; 
anaerobic threshold in relation to VO2peak) in the order: running > cycling > kayaking (i.e., best 
trained in running), indicating that a shift in training regime in favour of kayak training could 
result in better overall performance. Furthermore, a comparison between top and bottom 
finishers in the Adventure Racing World Championship 2006 showed that the best ranked male 
adventure racers were taller, had higher body mass and BMI, but no anthropometric differences 
were found between the female top and bottom finishers (Mattsson et al., submitted manuscript). 
Physiological characteristics of the participants in Study I-IV (separated between protocols) are 
shown in Table 1. 
 
Table 1. Subject characteristics 
 Age (years) Height (cm)  Body mass (kg) VO2peak (cyc) (ml · kg-1 · min-1) 
Men 
12-h (n = 8) 31 ± 4 181 ± 5  81 ± 6 62.2 ± 2.7 
24-h (n = 9) 27 ± 3 182 ± 4  80 ± 7  62.1 ± 5.3 
53-h (n = 17) 31 ± 6  181 ± 5  79 ± 7  53 ± 8 a 
5-7-day (n = 12) 27 ± 4  181 ± 5  81 ± 3  61.5 ± 3.8 b 
Women 
53-h (n = 3) 27 ± 1 167 ± 3   66 ± 5  50 ± 6 a 
5-7-day (n = 3) 30 ± 3 161 ± 7   56 ± 9  55.2 ± 2.6 
Values are means ± SD. a VO2peak values are estimated from submaximal cycling according to Åstrand and 
Ryhming (1954), b n = 11. 
 
 
In all studies the subjects were fully informed about the procedure, possible discomfort 
involved, and their right to withdraw from the experiment at any point. All subjects were 
previously well acquainted with the test methods. Written informed consent was obtained from 
all subjects. The design of the study was approved by the Regional Ethics Committee in 
Stockholm, Sweden, in compliance with the Declaration of Helsinki.  
 
3.1.1 Recruitment of subjects 
The protocols were performed in the chronological order: 24-h (fall 2005), 5-7-day (fall 2006), 
12-h (n = 4) (spring 2008), 53-h (fall 2008) and 12-h (n = 4) (spring 2009). The recruitment to 
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the first protocol was conducted through advertisements within the Swedish adventure racing 
community. All interested in participating sent their AR-specific curriculum vitae to the research 
group and the highest ranked athletes, based on experience and previous race results, were 
selected (nine plus two stand-ins). The 5-7-day protocol was the Adventure Racing World 
Championship which by itself indicates relatively high performance levels of the participants. 
All Swedish entrants were contacted during the month before the competition and informed 
about the research. The reason for only addressing the domestic teams was to ensure the 
possibility for tests before and after the race. All who volunteered were included in the 
investigations, and they belonged to teams that finished in 3rd to 24th place. The recruitment to 
the 53-h protocol was conducted in the same way as to the 5-7-day protocol. The essential 
difference (except exercise duration) was that the 53-h was a competition at a lower level, i.e., 
only less experienced Scandinavian teams. To the 12-h protocols two Swedish top teams, of 
each four athletes, were recruited.  
 
3.1.2 Gender perspective 
The female population in every endurance sport is consistently smaller than the male population. 
In adventure racing, women normally constitute 25%, or less, of the entire population. The main 
reason for this number is the gender mixed teams requiring at least one woman for every three 
men. In the 5-7-day protocol the rate of female volunteers is only one woman short of 25%. 
However, in the 53-h protocol all-male teams were allowed in a separate competition class 
which led to that only 15% of the subjects included in Study II were women. Due to the set-up 
with controlled individual relative intensity but exercise in coherent groups in the 24-h and 12-h 
protocols only men were recruited. 
 
3.1.3 12-hour controlled intensity (laboratory setting) 
Eight male, Swedish ultra-endurance athletes, each with several years of international elite level 
training and competition, participated in the 12 hour protocol. 
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3.1.4 24-hour controlled intensity (laboratory setting) 
Nine male Swedish ultra-endurance athletes with experience from several years of training and 
competition at international elite level participated in the protocol. The subjects had been 
training for the last 3-9 years for ultra-endurance competitions. They had previously belonged to 
the Swedish elite in various sports, and had completed several ARs with durations of more than 
48 h. Eight of the subjects had recent merits within top-10 in one or more of the world’s major 
competitions for teams (e.g., World Championship, “Primal Quest”). 
 
3.1.5 53-hour race situation (field setting) 
Seventeen male and three female Scandinavian ultra-endurance athletes of national level 
participated in the 53-h protocol. Compared to the other protocols these athletes were at a lower 
level of performance and had lower endurance capacity, which is evident in Table 1. The 
subjects also had a wider range of aerobic capacity, performance and training experience. 
 
3.1.6 5-7-day race situation (field setting) 
The subjects were 12 men and 3 women who participated in the Adventure Racing World 
Championship (ARWC) in Hemavan, Sweden. They were all well-trained ultra-endurance 
athletes with several years’ experience of training and competition at international top elite level, 
and eight of the participants belonged to one of the top-10 teams in the competition. An 
additional team (three men and one woman) of novice character without substantial experience 
was recruited to study III, but withdraw from the competition after just over 24 h due to general 
fatigue. They were therefore excluded from all analyses and their characteristics are not included 
in Table 1. 
 
3.2 STUDY DESIGNS AND EXERCISE PROTOCOLS 
 
3.2.1 Characterisation tests 
Two to four weeks before the 24-h and the 5-7-day protocols the athletes VO2peaks during cycling 
(Monark Ergomedic 839E, Monark Exercise AB, Varberg, Sweden), kayaking (Dansprint aps, 
Hovide, Denmark) and treadmill running (Rodby Electronics, Vansbro, Sweden) were measured 
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by incremental all-out tests with raised work rate every minute. The tests for the three disciplines 
were performed with at least 24 h of rest in between. VO2peak was reached according to Åstrand 
and Rodahl (1970) when: 1) total work time > 5 min, 2) levelling off of VO2 versus rate of work 
with VO2 on the highest work rate being within 150 ml · min-1 from previous highest obtained 
value in the tests (Taylor et al., 1955) and 3) subjective rate of perceived exertion > 16 (Borg 
1962). The inter-session CV for duplicate measurements on separate days according to this 
methodology in our laboratory is 2.6 %.  
 
The same type of VO2peak-test (cycling) was performed on the day before the 12-h protocol. 
Prior to the maximal test, on the same day, subjects performed incremental steady state tests 
(four steps of five min each) in order to establish the correlation between HR and VO2. 
 
In the 53-h protocol, VO2peak was estimated from the initial submaximal cycling measurement 
(Pre) according to the method of Åstrand and Ryhming (1954). This method has been validated 
in several studies, for example Ekblom et al. (2007). 
 
Figure 5: Correlations between heart rate (HR) and oxygen uptake (VO2) during different 
modes of exercise (kayaking, cycling, running) for a representative participant. 
 
 
Each data point was retrieved in steady-state conditions during the last minute of a 5-
min stage at a fixed work rate. (Enqvist et al., 2010) 
 
Prior to the all-out test subjects also performed incremental steady state tests (5 steps à 3 or 5 
min) in each discipline in order to establish relation between HR and VO2. The values used for 
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the correlation calculations were obtained lasting the final minute of each work rate. The mean 
coefficient of determination for the 12-h protocol (n = 8) was R2 = 0.985 ± 0.007 (cycling). 
Because of the different hemodynamic situations the HR:VO2-relation is specific to exercise 
mode (Figure 5). However, the mean coefficient of determination was reassuring for all 
disciplines in the 24-h protocol (cycling: R2 = 0.995; kayaking: R2 = 0.975; running: R2 = 
0.990; n = 9). The individual correlation in each discipline was used to control intensity and to 
determine the desired HR at the self-paced stages of the 12-h and the 24-h protocols. These 
correlations in combination with continuous HR-recordings were subsequently used for 
calculations of energy expenditure (Enqvist et al., 2010). 
 
3.2.2 12-hour controlled intensity (laboratory setting) 
The 12-h protocol began at 08:30 AM and consisted of almost continuous mixed exercise at 
controlled intensity. The subjects performed four blocks of ergometer cycling (Monark 
Ergomedic 828E, Monark Exercise AB, Varberg, Sweden) at a fixed work rate (175 W) for one 
hour each.  
 
Figure 6: Schematic view of the 12-h protocol – controlled intensity. 
Time of day
08:30 09:30 13:10 16:50  20:30
"0h" "4h" "8h" "12h"
0 1  2  3  4  5  6  7  8  9  10  11  12
Accumulated time (hours)
= outdoor exercise (running, kayaking, cycling) at intensi ty of 60 % of VO2-peak.
= ergometer cycling at fixed work rate (175 W), incl. measurements during the last 40 min of each period.
= time for change of equipment, food intake and rest (10 min).
 
Time points for conducted measurements at steady state ergometer cycling are marked 
“0h”, “4h”, “8h” and “12h”. (Study II) 
 
The assessment included measurements of cardiac output by a non-invasive gas rebreathing 
technique (CORB), VO2, HR and systolic and diastolic blood pressure. From those values 
VO2/HR, SV, a-v O2 diff, mean arterial pressure (MAP), stroke work (SW), cardiac work (CW), 
rate pressure product (RPP) and total peripheral resistance (TPR) were calculated. SW = SV x 
MAP, CW = SW x HR. RPP = HR x systolic blood pressure, is used as an indirect indicator of 
relative changes in the heart’s oxygen consumption. Relative changes in TPR can be calculated 
by dividing MAP by CO. Measurements as described above were conducted during the last 40 
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min of these blocks, denoted “0 h”, “4 h”, “8 h” and “12 h”. In between these blocks of 
ergometer cycling the subjects performed different kinds of outdoor exercise (cycling, running, 
kayaking) at a work rate aimed at 60% of the individual VO2peak. The intensity was continuously 
controlled using HR-monitors and corresponding HR. The subjects were allowed a total of 60 
min (6 x 10 min) for rest, food intake and change of equipment in the course of the entire 12 
hour exercise event (Figure 6). Intake of food and water was allowed ad libitum. 
 
3.2.3 24-hour controlled intensity (laboratory setting) 
The 24-h protocol was made up of almost continuous mixed exercise in a controlled setting. The 
study designs in both protocols in a laboratory setting allowed for repeated sampling and strictly 
controlled diet and work intensity. The athletes arrived in the laboratory following three days of 
standardised food intake of 4250 kcal/day (52% carbohydrates, 31% fat and 18% protein). A 
polyethylene catheter was inserted in an anticubital vein prior to exercise in order to facilitate 
repeated blood sampling. The subjects then, in groups of three, performed 12 blocks of exercise 
(4 x kayaking, 4 x running and 4 x cycling). Each block encompassed 110 min of exercise and 
10 min of rest for food intake and change of equipment and clothes. (Figure 7)  
 
Figure 7: Schematic view of the first 6 h of protocol 1: 24-h ultra-endurance exercise. 
 
 
The schematic view above shows the components and outline of the first block, after 
which there were three identical 6-h blocks. HR = heart rate. (Enqvist et al., 2010) 
 
The three groups all performed the disciplines in the stated order, but due to logistics the first 
group started at 10:00, the second at 11:50, and the third at 13:40. The energy intake during the 
exercise (consisting of 59% carbohydrates, 29% fat and 12% protein) was aimed to give each 
person 50% of their estimated energy expenditure. Intake of water was allowed ad libitum. All 
tests and the kayaking exercise were held in-doors with temperature ranging between 18 and 22 
°C. Running and cycling, except for the last 20 and 30 min of every exercise block, respectively, 
were performed outdoor. The temperature ranged between 2 °C at night and 22 °C during 
daytime. Work rate aimed at 60% of the individual VO2peak in respective exercise mode. For the 
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last 20 min of every exercise block of cycling (i.e., every 6th h) the work rate was standardised to 
125, 150 or 175 W depending on the subject’s VO2peak. The initial values (0 h) for steady-state 
cycling at standardised work rates were collected before the main test. The last 10 min of each 
block of running and ergometer kayaking were at individual fixed standardised work rates, 9 or 
10 km • h-1 with 1º incline and 65 to 85 W, respectively, depending on the subject’s VO2peak. 
HR-values for running and kayaking seen in Figure 12 are collected during the last 5 min of 
every exercise block.  
 
3.2.4 53-hour race situation (field setting) 
The experimental protocol studying 53 h of nearly continuous mixed exercise was performed as 
part of the TietoEnator Adventure Race held in Värmland, Sweden in May 2008. Subjects in 
teams of four (mixed gender or all male) completed a predetermined course of approximately 
500 km, with an estimated winning time of 52 h. The race started at 10:00 AM, and consisted of 
running, mountain bicycling, kayaking, inline-skating, and rope activities (Figure 8). Time for 
rest as well as intake of food and water were allowed ad libitum. All measurements (same as 
described in the 12-hour protocol) were conducted indoors during steady-state ergometer cycling 
(Monark Ergomedic 828E, Monark Exercise AB, Varberg, Sweden) at a fixed work rate (175 W 
for men and 125 W for women, >5 min) before the start (“Pre”), half-way through (“Middle”), 
and within thirty min after finishing (“Post”) the race. A compulsory stop approximately 
halfway through the race allowed the research team to administer the Middle measurements. 
 
Figure 8: Schematic view of the 53-h protocol – adventure race. 
Time of day
10:00 18:00 24:00 06:00 12:00 18:00 24:00 06:00 12:00 
0 5 10 15 20 25 30 35 40 45 50 54
Accumulated time (hours)
= Running, trekking
= Mountainbike cycling
= Inline skating
= Kayaking
= Other exercise activities (ropeworks, manual railway trolleying)
= Mandatory stop incl. measurements ("Middle") at indoor ergometer cycling at fixed work rate (Men 175 W, women 125 W).
= Time for change of equipment, food intake and rest.
 
The timeline describes the duration of the race stages for the median team, with total 
race time of 54 h 20 min. The “Middle” measurement at steady state ergometer cycling 
is indicated within the timeline. The measurements “Pre” and “Post” were conducted 
before and within 30 min after the race. (Study II) 
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3.2.5 5-7-day race situation (field setting) 
The race completed by our subjects involved non-stop of running, mountain biking, kayaking, 
in-line skating, climbing, caving and canyoneering on a predetermined course of more than 
800km, which was to take approximately 5-6 days for the winning team as estimated by the 
organisers of this event. The subjects competed in teams consisting of three men and one 
woman. Sleeping, resting, eating and drinking were allowed ad libitum. The average intensity of 
exercise during this race has been reported elsewhere to be approximately 40% of VO2 peak, with 
a total energy expenditure of 80 000 kcal, or approximately 525 ± 100 kcal • h-1 (Figure 9) 
(Enqvist et al., 2010). 
 
Figure 9: Energy expenditure per hour for two teams during the 5-7-day protocol. 
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Each point indicates mean energy expenditure (EE) during one hour (n = 6 divided into 
two teams). Solid symbols are team 1 with a total race time of 142 h 14 min, and open 
symbols are team 2 with a total race time of 157 h 31 min. (Enqvist et al., 2010) 
 
Since the measurements were carried out during an actual competition, participants prepared 
themselves individually prior to the race and did not adhere to a standardised pre-study diet with 
a following overnight fast. 
 
3.3 METHODS 
3.3.1 Heart rate measurements 
HR was continuously recorded with a HR-monitor 610S (Polar Electro Oy, Kempele, Finland), 
validated against electrocardiogram (Moore et al., 1997; Porto and Junqueira, 2009).  
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3.3.2 Blood pressure measurements 
Blood pressure was measured using an aneroid sphygmomanometer (12 x 35 cm, Umedico AB, 
Rosersberg, Sweden) around upper arm. Presented data is an average of duplicates tests. All 
measurements were performed by two trained operators. 
 
3.3.3 Blood samples and biochemical methods 
In the 12- and 24-hour protocol blood samples were drawn from a forearm vein at seated rest 
before exercise (Pre-Ex) and during the periods of steady state cycling. 
 
In the 53-h and protocols blood samples were drawn with the subject at a seated rest position, in 
the morning the day before the race (Pre-Ex) and immediately after the end of the race (Post-
Ex), and also in the 53-h after half of the race (Middle) and in the 5-7-day after 24 h of recovery 
(Rec-24h). Samples Post-Ex, Middle and Rec-24h were drawn at different times of day 
depending on the participants’ performance and race time.  
 
Catecholamines in plasma were determined after absorption to alumina at basic pH and 
desorption with perchloric acid. The catecholamines (Epi, NE) were separated using a high-
pressure liquid chromatograph (HPLC) with a strong cation exchange resin and an 
electrochemical detector. Coefficients of variation (CV) were reported to be 7 and 8%, 
respectively (Hallman et al., 1978).  
 
Hematocrit (Hct) and concentration of haemoglobin [Hb] in venous blood were determined 
using ADVIA™ 120 (Bayer Diagnostics, Leverkusen, Germany). CVs were 1.9 and 1.8%, 
respectively. 
 
Plasma levels of creatine kinas isoenzyme MB (CK-MB), troponin I, and NT-proBNP were 
determined using sandwich enhanced chemiluminescence immunoassay (ECLIA) methodology 
analysed using Modular E170 (Roche Diagnostics Sweden AB, Bromma, Sweden). BNP in 
plasma was measured with a direct (without extraction) immunoradiometric assay (IRMA) 
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(Shionoria BNP, Cis Bio International, Elektrabox, Sweden). This is a sandwich-type IRMA, 
using two monoclonal antibodies prepared against two sterically remote epitopes of the human 
BNP molecule. The intra-assay coefficient of variation was 2% for CK-MB, 2% for troponin I, 
1% for NT-proBNP and 6% for BNP. All samples were determined within the same assay to 
avoid inter-assay variation. 
 
3.3.4 Oxygen uptake measurements 
Oxygen uptake (VO2) was measured using different methods in the different studies.  
 
For the characterisation tests in the 24-hour protocol VO2 was measured with an online 
ergospirometry system (AMIS 2001, Innovision A/S, Odense, Denmark) based on mixed 
expired method with an inspiratory flowmeter. Before each test temperature, humidity and 
barometric pressure were measured, and gas analysers and inspiring flowmeter were calibrated. 
High precision gases (15.00 ± 0.01% O2 and 6.00 ± 0.01% CO2, Air Liquide, Kungsängen, 
Sweden) and indoor air were used for gas analyser calibration. The flowmeter was calibrated 
with a 3.0-liter syringe (Hans Rudolph Inc, Kansas City, MO, USA) at low, medium, and high 
flow velocity. The system’s accuracy compared to the Douglas bag technique has a CV of 2.4% 
(Jensen et al., 2002). 
 
At the 24-h exercise VO2 was measured during the last minutes of steady state periods using the 
Douglas bag technique. Expired air was collected and measured in duplicate bags. The volume 
of the expired air was measured with a Tissot spirometer (WE Collins, Braintree, MA, USA) 
and fractions of oxygen and carbon dioxide were determined using S-3A and LB2 gas analyser 
(Beckman Instruments, Fullerton, CA, USA), respectively. 
 
In the 12-hour, 53-hour and 5-7-day protocols VO2 was measured with an online ergospirometry 
system (Oxycon Pro, Erich Jaeger GmbH, Hoechberg, Germany) based on mixed expired 
method with an inspiratory flowmeter. The values presented in the results are means of duplicate 
tests. The system’s accuracy compared to the Douglas bag technique has a CV of 1.2% (Foss 
and Hallén, 2005). Before each test, ambient temperature, humidity and barometric pressure 
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were measured, and gas analysers and inspiratory flowmeter were calibrated. High precision 
gases (15.00 ± 0.01% O2 and 6.00 ± 0.01% CO2, Air Liquid, Kungsängen, Sweden) and ambient 
indoor air were used for gas analyser calibration. 
 
3.3.5 Cardiac output measurements 
CORB was measured as the mean of two tests at each point using a foreign gas rebreathing 
technique (Innocor®, Innovision A/S, Denmark), in which the subjects breathe a gas mixture in a 
closed system with a constant ventilation rate. The gas mixture consists of the test gas (1% SF6 
(inert blood insoluble gas), 5% N2O (inert blood soluble gas) and 50% O2, (Innovision A/S, 
Denmark)) diluted 1:4 with ambient indoor air. The logarithmically transformed disappearance 
curve of N2O is proportional to pulmonary capillary blood flow which, in the absence of 
significant pulmonary shunts, equals cardiac output. Duplicate measurements were performed, 
separated by at least three minutes to allow for complete inert gas clearance. This method has 
been described in detail elsewhere (Clemensen et al., 1994), and has been validated against both 
the direct Fick and thermodilution methods during resting conditions (Gabrielsen et al., 2002) as 
well as during exercise (Agostini et al., 2005). During the last couple of years, the use of this 
method has expanded and also been evaluated in healthy subjects in several different studies; 
validity compared to other rebreathing methods at rest and during exercise (Jakovljevic et al., 
2008); validity compared to other non-invasive methods, Doppler ultra-sonic (Saur et al., 2009a) 
and cardiovascular magnetic resonance imaging (Saur et al., 2009b). In all these studies the 
method has been shown to as good as, or better, than other non-invasive measurements. In 
addition, the effects of variation in methodological variables such as breathing frequency and 
volume, intervals between rebreathing, and volume of dead space have been described 
(Damgaard and Norsk, 2005). Intra-session CV has previously reported to be 4.8% during 
resting conditions (Jakovljevic et al., 2008), and 4.3% during exercise at 130 W (Fontana et al., 
2009).  
 
To evaluate the reliability of this inert gas rebreathing method (Innocor®) during heavier 
exercise, and to clarify as to whether the technical error of measurement is of relative or absolute 
type we performed a reliability study (Mattsson et al., in manuscript). In total, 39 subjects (9 
female and 30 male, age 31 ± 7 years, height 177 ± 9 cm, weight 76 ± 13 kg) were recruited and 
they performed in total 95 duplicate tests, at rest (n = 10) and over a large range of exercise work 
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rates (n = 85). The inert gas rebreathing method appears to be a reliable assessment method for 
cardiac output in healthy subjects during exercise. A comparison of the difference in CORB 
between the measurements at rest (n = 10, CORB 6.2 ± 1.3 L • min-1) and the highest values 
during exercise (n = 10, CORB 22.0 ± 1.0 L • min-1) showed no significant difference (P = 0.97), 
indicating that the error is not relative to the absolute value. The CV was 3.7%, (n = 95, 95% CI 
2.9 to 4.5%), but we found a difference in averaged CV between 10.3% for resting 
measurements (n = 10, 95% CI 6.6 to 13.9%) and 2.9% during exercise (n = 85, 95% CI 2.4 to 
3.4%). The absence of systematic difference between tests is important and indicates that no or 
only marginal learning effects are present, even though the assessment situation is a quite 
demanding task for the subject. The absolute measures of reliability (limits of agreement (LoA) -
1.9 to 2.0 L • min-1) indicate that any individual increase between two measurement less than 2.0 
L • min-1, or decrease less than 1.9 L • min-1 may be interpreted as within measurement error 
(due to instrument and/or biological variation) (Figure 10). Further, no systematic error seems to 
be present, indicated by the non-significant difference between average difference at low and 
high intensity.  
 
Figure 10: Reliability of duplicate measurements of cardiac output using Innocor® (non-
invasive re-breathing) (Mattsson et al., in manuscript). 
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To conclude, duplicate measurements of cardiac output using the Innocor® is not biased and 
has acceptable reliability, higher than other non-invasive alternatives. The technical error is of 
absolute type, and stable over the full range of measured values (Mattsson et al., in 
manuscript). 
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3.3.6 Rated relative performance  
In the 5-7-day protocol each athlete rated his/her own performance during the last 12 h of the 
race on a scale from 1 to 3, where 1 = good, strong, carried extra weight, helped/pulled 
teammate, 2 = intermediate, took care of oneself, 3 = poor, weak, took help from teammate(s). 
In addition each athlete was rated according to the same scale by the other three members of 
his/her team. Thereafter the four ratings of each participant were pooled to give one value of 
relative performance.  
 
It is important to mention that the rating is in relation to the rest of the team rather than race 
result, and also an indication of the participants’ normal individual performance. Since a part of 
our hypothesis is that cardiac fatigue is induced by relative exercise intensity and load we 
consider it irrelevant to relate increase in cardiac biomarkers with race results. The study 
protocol, an ultra-endurance race situation, was suitable in part for the extreme duration and in 
part because the participants competed in teams of four. Regardless the team’s ambition (i.e., to 
finish top or bottom) each team is normally composed of participants with similar exercise 
capacity. Usually, each team has trained and competed together several times before and the 
teammates are therefore familiar with what should be considered “normal/intermediate 
performance” for him-/herself and the other team members. This rating scale has never been 
used before and is not validated; therefore we can at this point only provide an exploratory and 
descriptive value of performance. The scale is very simple with only three steps. The small 
number of scale steps limits the possibility of detecting small nuances but increases the 
consistency in rating. Accordingly, there is very good consistency in the evaluation of the 
performance for each participant. For twelve of the fifteen participants the assessments are 
unanimous, i.e., the same value in all ratings. 
  
If a subject’s performance is rated high or low will very likely be affected by a vast number of 
factors other than cardiac fatigue, for instance skeletal muscle fatigue, central fatigue, energy 
deficiency and sleep deprivation. However, for the purpose of this thesis such confounding 
factors have not been taken into account, due to low numbers of participants. Residual 
confounding is therefore likely to be present. 
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3.3.7 Echocardiography and Tissue velocity imaging 
While resting in a left lateral recumbent position the subjects’ hearts (sizes and myocardial 
velocities) were recorded at baseline, immediately after the race, and after one day of recovery 
by the same clinically experienced operator using both 2D-gray scale images and tissue velocity 
imaging (TVI) (VIVID I, GE VingMed Ultrasound, Hortens, Norway) with a standard 2D 
transducer (M3S). 2D recordings were obtained from the parasternal long axis (PLAX), and 
apical two-chamber (2CH) and four-chamber views (4CH) using both the 2D and TVI 
procedures. The colour TVI images with high temporal resolution were stored in cine-loops 
containing a minimum of three consecutive heartbeats. On the basis of the 4CH and 2CH views 
a circular region of interest (ROI) with a size of 4 mm was chosen at the basal segment of both 
the two left ventricular walls and the right ventricular free wall. No temporal filter was applied 
during the post-processing. All echocardiographic data were stored digitally (EchoPac 
workstation, GE VingMed Ultrasound) and subsequently analysed off-line utilising Matlab 7.0.1 
to determine manually the isovolumic contraction velocity and duration (IVC v and t), peak 
systolic velocity (PSV), isovolumic relaxation velocity and duration (IVR v and t), and peak 
early (E’) and late diastolic (A’) velocities. 
 
From the M-mode recordings the wall thickness and dimensions of the LV were calculated 
applying the leading edge-to-edge convention of the American Society of Echocardiography 
(ASE), in which a single representative cardiac cycle exhibiting the largest possible length of the 
LV cavity is used (Henry et al., 1980). LV mass was calculated in accordance with the formula 
recommended by the ASE (Lang et al., 2005) and this mass then related to body surface area 
(Mosteller, 1987), as well as to fat-free body mass, the latter being optimal according to 
Batterham and George (1998). All of these measurements were made during diastole. 
 
The ejection fraction was calculated from the displacement of the plane of the atrioventricular 
valve (AV) according to a modification (Alam et al., 1990) of the approach developed by 
Höglund and colleagues (1988; 1989). 
 
The specific example of the TVI machine VIVID I used in our study was tested for validity 
compared to a computer programmed phantom.   
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Figure 11: Validity and reliability of tissue velocity measurements using VIVID I.  
 
 
The phantom was programmed after a healthy subject’s displacement curve measured basal in 
septum. The readings were very satisfying with close agreement (Figure 11). The average error 
for measurements of velocity was -0.6 cm • sek-1 with SD 0.2 cm • sek-1, and for displacement 
even lower (close to 0) (n = 30). 
 
3.4 STATISTICS 
The same types of statistical analyses were performed in study I-IV using Statistica for 
Windows, version 8 (StatSoft Inc., Tulsa, OK, USA). Data are generally presented as means ± 
SD (in some cases min and max values are also presented) and were confirmed to be normally 
distributed using the Shapiro-Wilks W-test before performing parametric statistics. Repeated 
measures ANOVA were employed to analyse changes over time in all parameters. When an 
effect was detected a post-hoc analysis was performed with the Tukey HSD test. If the data did 
not conform to the assumption of sphericity, the P-value was subjected to Huynh-Feldt 
correction. A P-value of < 0.05 was considered to be statistically significant. Trends were 
considered at 0.05 < P < 0.1. 
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4 RESULTS 
 
4.1 PHYSIOLOGICAL PARAMETERS AND MISSING DATA 
4.1.1 Study I 
The total estimated average work intensity (in per cent of respective VO2peak) during the 24-h 
exercise was approximately 55% with the time for rest, food intake and change of equipment 
and clothes included. The calculation is adjusted according to the observed cardiovascular drift. 
There were no significant differences in work rate between the four different exercise blocks in 
the same discipline. There were no significant changes in Hb or Hct during the 24-h exercise, 
indicating maintained hydration and blood volume, according to formula by Dill and Costill 
(1974). The catecholamines, Epi and NE, both increased from Pre-Ex continuously during 
exercise, but decreased at rest at Rec to approximately halfway to Pre-Ex.  
 
All subjects, but one, were able to perform all periods of standardised work rate. The 
unsuccessful participant failed to maintain his work rate during the last measurements due to 
general fatigue. He is therefore excluded from the results, even though his response patterns in 
all parameters until then were similar to the others.  
 
4.1.2 Study II 
The average time of exercise for the 12-h and 53-h protocols was 11 h 44 min ± 5 min and 53 h 
14 min ± 5 h 18 min, respectively. The “Middle” measurements were performed 20 h ± 2 h 30 
min into the race. The outdoor temperature ranged between 3-5 °C during the12 h, and between 
9-16 °C during the 53-h protocol. All measurements in both protocols were conducted indoor at 
temperature ranged between 18-22 °C. 
 
The estimated average work rate (in per cent of cycling VO2peak) during the 12 h exercise 
protocol was 55 ± 3% of VO2peak, including the periods for rest, food intake and change of 
equipment. The estimated average work intensity for the 53 h competition was 37 ± 5% of 
VO2peak (calculation made from ten subjects with complete HR-recordings). The VO2 during the 
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first bout of standardised ergometer cycling was 51 ± 2% of VO2peak in the 12-h protocol and 49 
± 6% of VO2peak in the 53-h protocol. 
 
All subjects completed the assigned 12-h or 53-h protocols and all blocks of standardised 
ergometer cycling. However, in the Middle measurement during the 53 h event, VO2 data was 
missing from three subjects and HR and CORB data from one subject due to technical problems. 
 
4.1.3 Study III and IV 
The competition/exercise protocol took place under normal Nordic summer climate conditions 
with air temperatures during the day and night of 20-25 and 10-15oC, respectively. The average 
time for completion of the race was 147 ± 11 h, and our subjects belonged to teams that finished 
in 3rd to 24th place. 
 
One team recruited to study III (n = 3 men and 1 woman) dropped out after only 24 h of racing 
due to general fatigue. They were therefore excluded from the analyses. The remaining 
participants were the same as recruited for study IV. 
 
4.2 CIRCULATORY ADAPTATION 
4.2.1 Heart rate (HR) 
In the 24-h protocol HR at standard work rate in cycling was increased at six hours with 13 ± 
6% compared to 0 h, but thereafter there was a decrease towards initial values throughout the 
exercise. HR was fully recovered after 24 h of recovery. The initial increase and following 
decrease were similar in all exercise modes (Figure 12).  
 
This kinetics of the drift was verified in the 12-h protocol were HR was increased at 4 h 
compared to 0 h, but thereafter drifted back towards initial values, although still elevated at 12 h 
compared to 0 h. HR had decreased below Pre at both the Middle and Post testing phases of the 
53-h protocol.  
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Figure 12: Mean changes in heart rate (HR) at standardised work rate in different 
exercise modes during 24-h ultra-endurance exercise. (Study I) 
0
2
4
6
8
10
12
14
16
0 2 4 6 8 10 12 14 16 18 20 22 24
Sample time (h)
∆
H
R
 
(be
at
s 
·
 
m
in
-
1 ) Kayak
Running
Cycling
 
 
4.2.2 Oxygen uptake (VO2) 
There were increases in VO2 at standardised work rate at all points of measurement compared 
to Pre in all protocols. In the 24-h protocol VO2 was increased at 6 h with 10 ± 6% and at 12 h 
with 17 ± 8% compared to 0 h, and thereafter VO2 remained increased throughout the exercise. 
In difference to HR the VO2 showed a trend towards maintained elevation at Rec (P = 0.07). 
During the 12-h protocol, VO2 was significantly increased at 8 and 12 h (10 ± 5%) versus 0 h. 
Similarly, VO2 increased during the 53 h event both at Middle (7 ± 4%) and Post (4 ± 5%) 
compared to Pre. However VO2 at Post had slightly decreased (-2.4%, P < 0.05) compared to 
Middle  
 
4.2.3 Oxygen pulse (VO2/HR) – Work efficiency 
The VO2/HR, expressed in ml O2 • heartbeat-1, in the 24-h protocol the VO2/HR was not 
changed at 6 h compared to 0 h but increased with 7 ± 10 (-3-21), 13 ± 11 (0-32) and 11 ± 10 (-
3-26) % compared to 0 h at 12, 18 and 24 h, respectively. At Rec VO2/HR had decreased 
approximately halfway towards initial values. This circulatory adaptation was verified in both 
the 12-h protocol were VO2/HR was increased at 8 h and 12 h compared to 4 h, and in 53 h 
event, VO2/HR was increased both at Middle and Post compared to Pre.   
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4.2.4 Cardiac output, stroke volume and work of the heart 
During submaximal exercise CORB remained largely unchanged in the 12-h and 53-h protocols. 
However, statistically significant findings were a decreased CORB at 12 h compared to 8 h in the 
12-h protocol and an increased CORB at Post compared to Middle in the 53-h protocol. The 
calculated SV during the 12-h protocol was decreased at 4 h compared to 0 h, but returned 
thereafter towards baseline levels. In the 53-h protocol SV was elevated at Post compared to Pre. 
In the 12-h protocol a-v O2 diff remained unchanged at 4 and 8 h but increased at 12 h compared 
to 0 h. In the 53-h protocol it was increased from Pre to Middle, but decreased from Middle to 
Post, but in that protocol there was no difference between Pre and Post. There was a correlation 
between change in VO2 and change in a-v O2 diff from Pre to Post in the 53-h protocol (P < 
0.001, r = 0.73) (Figure 13). A trend towards the same correlation was noted between 0 h and 12 
h in the 12-h protocol (P = 0.07, r = 0.67). Mean arterial pressure (MAP) was constant during 
the 12-h protocol, but decreased at both Middle and Post compared to Pre in the 53-h protocol.  
 
Figure 13: Correlation of changes in oxygen uptake and arterio-venous oxygen difference 
after 53 h of adventure racing. 
 
 
Per cent change in oxygen uptake (VO2) at steady state ergometer cycling versus per 
cent change in calculated arterio-venous oxygen difference (a-v O2 diff) comparing 
beginning and end of a 53-h adventure race (n = 20). Dashed line represents 95 % CI. 
Correlation r = 0.73, P < 0.001. (Study II) 
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Apart from a decrease at 4 h (P < 0.01) in accordance with the traditionally defined early 
cardiovascular drift, SW was unchanged compared to Pre throughout both experiments. There 
were no differences in CW during the 12-h protocol. However, CW was decreased at Middle 
and Post compared to Pre in the 53-h protocol. In the 12-h protocol there were no changes in 
RPP, but at the 53-h protocol RPP was decreased at Middle by 15% and at Post by 11% 
compared to Pre (both with P < 0.001). Similar to CW, RPP and MAP we found a decreased 
TPR at Middle and Post in the 53-h protocol of 7 and 13% (P < 0.05 and P < 0.01), respectively, 
but there were no changes in the 12-h protocol.   
 
4.3 CARDIAC FATIGUE 
4.3.1 Cardiac biomarkers 
The levels of CK-MB, BNP and NT-proBNP [mean ± SD (min-max)] at Pre-Ex, Post-Ex and 
Rec-24 are shown in Table 2. The levels of all these biomarkers in plasma were elevated at Post-
Ex compared to Pre-Ex. At Rec-24 levels were decreased, but still elevated compared to Pre-Ex. 
However, only 20% of the participants (n = 3) had elevated levels after the exercise (0.05, 0.06 
and 0.10 µg · l-1). Two of them still displayed elevated levels at Rec-24 (0.05 and 0.08 µg · l-1). 
The correlation between levels of NT-proBNP and BNP at Post-Ex was excellent (R2 = 0.95), 
but there was no correlation between NT-proBNP and CK-MB (R2 = 0.09). 
 
Table 2. Cardiac biomarkers in plasma before (Pre-Ex) and immediately after (Post-Ex) a 6-
day Adventure race, and 24 h into recovery (Rec-24h) (n = 15) 
 Pre-Ex  Post-Ex Rec-24h   
CK-MB (µg · l-1) 5 ± 1 (2-7) 37 ± 14 (12-60)* 17 ± 7 (6-30)* # 
Troponin I (µg · l-1) n.d. elevated in 3 subjects elevated in 3 subjects 
BNP (ng · l-1) 11 ± 6 (n.d.-23) 41 ± 46 (n.d.-160)* 22 ± 18 (n.d-63)* 
NT-proBNP (ng · l-1) 31 ± 14 (10-56) 487 ± 648 (52-2480)* 224 ± 219 (12-634)* 
Values are means ± SD (min-max). * P<0.05 vs Pre-Ex, # P<0.05 vs Post-Ex. CK-MB, creatine kinase mb-
fraction; BNP, B-type natriuretic peptide: NT-proBNP, N-terminal prohormone of B-type natriuretic peptide; 
n.d., not detectable (<0.03 µg · l-1). 
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4.3.2 Echocardiography – Cardiac size 
The echocardiographic measurements revealed that the hearts (LV) of these adventure-racing 
athletes, although enlarged, were within normal limits. Compared to athletes participating in 
other endurance sports, such as cycling, cross-country skiing and canoeing both wall thickness 
and the diameter of the left ventricular cavity diameter were similar in our subjects, but not quite 
as large as those in rowers Pelliccia et al., 1991; Spirito et al., 1994). The LV mass measured in 
study IV (men 223 ± 27 g and women 114± 20 g; or related to fat-free mass: men 3.3 ± 0.4 g · 
kg-1 and women 2.6± 0.2 g · kg-1) was slightly lower than that found for Swedish male cross-
country skiers (250 g, or related to fat-free mass, 3.9 g · kg-1) (Carlsson et al., in press). The 
highest individual values for baseline cardiac size were demonstrated by a man; the thickness of 
the LV postural and intraventricular septal walls both 12 mm; the LV diameter, 60 mm; LV 
mass, 280 g; LV mass related to BSA, 138 g · m-2, and related to lean body mass, 4.05 g · kg-1. 
The highest corresponding values for a woman were 9 and 8 mm, respectively; 48 mm; 137 g; 
79 g · m-2 and 2.73 g · kg-1.  
 
The functional measurements showed that HR increased from 50 ± 7 to 58 ± 10 bpm comparing 
baseline to after the 5-7-day protocol. Measurements of E/A at the same time points decreased 
from 2.3 ± 0.6 to 1.8 ± 0.4, but EF increased from 59 ± 8 to 70 ± 8%. At all assessments, 
average LVd was stable at 53 mm. 
 
4.3.3 Tissue velocity imaging 
The values from tissue velocity assessments are shown in Table 3. Basically, all values are 
within normal limits. The contraction velocity in LV is increased HR after the exercise. The total 
duration of each cardiac cycle is decreased (i.e., higher HR) and, consequently, contraction and 
relaxation times are decreased, except for the RVfree wall. Twenty per cent of the subjects 
displayed any IVRt at baseline, and the incidence of such relaxation duration increased to 60% 
at both of the later measurements.  
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Table 3. Tissue velocity parameters at baseline, after a 6-day Adventure Race and following 24 
hours of recovery (n = 15) 
 Baseline  After exercise Following recovery  
IVCv LV (cm · s-1) 3.36 ± 1.26 4.97 ± 2.53* 4.60 ± 2.36* 
IVCt LV (ms) 89 ± 26 69 ± 22* 73 ± 22* 
IVRt LV lateral wall (ms) 78 ± 25  71 ± 24* 70 ± 23 
IVCv RV (cm · s-1) 8.42 ± 2.13 7.60 ± 2.98 8.24 ± 3.11  
IVCt RV (ms) 80 ± 17 67 ± 15*  68 ± 16* 
IVRt RV a (%) 20 60 60 
The values presented are means ± SD. IVC, isovolumic contraction (v, velocity; t, duration; LV, left ventricle – as 
mean of septal and lateral walls; RV, free wall of the right ventricle); IVRt, duration of the isovolumic relaxation. 
% of the subjects exhibiting IVRt RV of any duration. * P <0.05 compared to the corresponding baseline value, # 
<0.05 compared to the corresponding value after exercise. 
 
 
The peak systolic velocities at baseline and immediately after exercise and after approximately 
24 h of recovery were similar, except for significant increases in the septal wall velocity after 
exercise compared to baseline and in the velocity of the right ventricular free wall following 
recovery in comparison to immediately after exercise (Figure 14).  
 
Figure 14: Peak systolic velocities (cm · s
-1
) in different segments of the myocardium at 
rest at baseline, after approximately 150 h of continuous exercise (After), and following 
24 h of recovery (Recovery) (n = 15). 
 
LV, left ventricle; RV, right ventricle. * P <0.05 compared to the corresponding baseline 
value, 
#
 P <0.05 compared to the corresponding value after exercise. (Study IV) 
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5 GENERAL DISCUSSION 
 
5.1 CIRCULATORY ADAPTATION 
This thesis confirms the well-established drift in HR during the first six hours of exercise, seen 
in earlier investigations (Åstrand 1960; Saltin and Stenberg 1964). After six hours there was 
an unexpected change. Instead of an increased or continuous rise in HR there was a decrease 
with time towards initial values at the end of exercise. Meanwhile, VO2 at the standardised 
work rate increased with approximately 10-15% at 12 h, and thereafter remained stable until 
the end of exercise. The magnitude of the increased VO2 at 12 h was approximately three 
times greater than previously reported.  These two drifts combined gave an increased VO2/HR 
which indicates that the distribution of blood, and thus oxygen, was changed towards a more 
efficient energy distribution.  
  
5.1.1 Heart rate (HR) 
HR drifted in a similar way in both Studies I and II, with a continuous gradual increase during 
the first hours and thereafter a downward drift towards baseline. Interestingly, the inverted 
drift occurred even though Hb was decreased at the final measurements in the 12-h protocol, 
which in the literature is associated with incremental increases in both HR and CO (Ekblom et 
al., 1972; Woodson et al., 1978), since the decrease in Hb, with stable Hct, implies a 
decrement in oxygen-carrying capacity of 4.3% (Dill and Costill, 1974). This Hb decrease 
might be ascribed in part to the continuous mechanical trauma to the soles of the feet 
(Davidson, 1964). Such a haemolytic state is not without risk, and may in a worst case 
scenario induce kidney failure.  
 
The reversed HR-drift could be associated with desensitisation of the heart’s adrenergic 
receptors caused by high concentrations of catecholamines over an extended period of time 
(Eysmann et al., 1996; Friedman et al., 1987; Welsh et al., 2005; Hart et al., 2006). In 
agreement with this hypothesis, epinephrine and norepinephrine measured in Study I were 
continuously increased. Furthermore, another reasonable contributor to the reversed drift is a 
redistribution of blood flow from peripheral areas (e.g., skin) to working muscles. In this case, 
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it would imply restored preload, which is in accordance with earlier findings (Ashley et al., 
2006). 
 
5.1.2 Oxygen uptake (VO2) 
The VO2 at standardised work rate was increased above baseline at every time point in all 
protocols.  
 
The explanation might be found in a combination of adaptations. One parameter that would 
give increased oxygen cost during exercise is a change in metabolic substrate. For example, in 
Study I respiratory exchange ratio (RER) at the fixed work rate decreased from 0.88 to 0.83. 
This shift indicates a higher rate of fat utilisation, from 39 to 56%, according to the table by 
Zuntz (1901). Further calculations indicate an energy expenditure of 11.03 kcal • min-1 during 
initial cycling (VO2 2.25 l • min-1 and RER 0.88 corresponding to 4.90 kcal • l O2-1). If the 
work efficiency remained stable at the standardised work rate, the metabolic shift (decreased 
RER) would only give a minimal increase in VO2 to 2.28 l • min-1 (+0.03 l • min-1). 
Consequently, the metabolic shift is just a minor contributor to increased VO2. Another 
possibility is that increased pulmonary ventilation (VE) would result in a higher VO2. The 
oxygen cost of breathing becomes progressively greater with higher pulmonary ventilation, 
and may be up to 10% of total oxygen uptake during maximal exercise (Åstrand and Rodahl, 
1970). This means for our subjects in Study I, with a VO2max of ≈ 5 l • min-1 and a maximal VE 
of approximately 200 l • min-1 the maximal oxygen cost of breathing will be 2.5 ml per litre of 
inspired air. Even if maximal values are used for calculations the oxygen cost for the increased 
VE is less than +0.02 l • min-1. These calculations lead to the suggestion that the central 
circulatory adaptation only explain less than 15 % of the increased VO2. Instead, the changes 
in VO2 should mainly be attributed to peripheral (muscular) adaptations. A study on 
mitochondria from musculus vastus lateralis in the subjects that participated in the 24-h 
protocol showed a reduced mitochondrial efficiency, with both palmitioylcarnitine and 
pyruvate as substrates, by 9 and 6%, respectively (Fernström et al., 2007). This efficiency 
reduction could be a major contributor to the increased VO2. Study II support this hypothesis, 
as shown by the direct correlation between change in VO2 and change in a-v O2 diff from Pre 
to Post in the 53-h protocol (Figure 13).  
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The remaining portion of the VO2-drift could be ascribed to decreased economy of movement 
by recruiting alternate muscle fibres during prolonged exercise (Dick and Cavanaugh, 1987), 
without muscle damage (Westerlind et al., 1992), but still other causes are possible.  
  
The magnitude of the increased VO2 was highest in the 24-h protocol, for measurements from 
12-h and after. In the 53-h protocol the increase at Middle was approximately half compared to 
the highest observed drift in the 24-h protocol. There was a decrease in VO2 at Post compared to 
Middle. Even though all measurements were conducted at standardised work rate, the major part 
of the exercise performed in the 53-h protocol was in the form of a competition. During this type 
of race, the work intensity decreases over time (Lucas et al. 2008; Enqvist et al., 2010). This 
time-dependent decrease in external work intensity may explain the relative decrease of VO2. 
The 53-h protocol was obviously longer but with lower average work intensity compared to the 
12-h and 24-h protocols. In the study by Saltin and Stenberg (1964), subjects exercised at 75% 
VO2peak for three hours, generating a 5% increase in VO2. Therefore it could be suggested that 
the magnitude of the upward drift in VO2 is dependent on both exercise duration and relative 
work intensity. 
 
5.1.3 Oxygen pulse (VO2/HR) – Work efficiency 
The combination of the two cardiovascular drifts described above also give an unexpected 
increase in VO2/HR after the first six hours of exercise. In the 12-h protocol the lowest levels 
were found at 4 h. The values were then increased at 8 h and 12 h, and VO2/HR was increased 
above initial level in all measurements during the 53-h protocol. Normally, an increased VO2 
at submaximal work rate would be covered by an increased CO, usually by increased HR. In 
the present thesis VO2/HR was increased despite the elevated VO2 and reduced mitochondrial 
efficiency (Fernström et al., 2007). This indicates that the distribution of blood, and thus 
oxygen, was changed towards a more efficient energy distribution. The increased VO2/HR can 
be either a result of central circulatory adaptation (i.e., increased SV), or higher peripheral 
extraction, (i.e., increases in a-v O2 diff, possibly by altered distribution of blood to, and 
within, working muscles). Study II revealed that a combination of the two might be the 
answer. During the first approximately 24 h of exercise the increased VO2/HR is covered by 
increased a-v O2 diff, but at the last measurement in the 53-h protocol the late cardiovascular 
drift was occurring, including increased SV and normalised a-v O2 diff. 
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There are large differences in the response between subjects. These differences are not 
correlated to relative work rate, decreases in body weight, or concentration of catecholamines 
at the end of exercise. In the 24-h protocol the increased VO2/HR during cycling at 18 and 24 
h compared to 0 h is highly correlated to calculated mean VO2 (l • min-1) during the whole 24-
h ultra-endurance exercise session. The individual values are plotted in Figure 15, which 
indicate that the higher the total oxygen flux, the greater the increase in VO2/HR. The 
explanation and the implications of this are not yet known. 
 
Figure 15: Correlation between calculated mean oxygen uptake (VO2) during 24-h ultra-
endurance exercise (l • min
-1
) and increased oxygen pulse (VO2/HR) (mL O2 • beat
-1
) 
during cycling, at 18 and 24 h compared with 0 h (initial value) (%) in eight subjects (r = 
0.90; P <0.01). (Study I) 
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5.2 CARDIAC FATIGUE 
Based on the results from this thesis we conclude that a late cardiovascular drift is present 
during this type of ultra-endurance exercise (Study I; Study II). This late drift involves 
increases in both SV and cardiac output (CO) at a standardised work rate, probably as a result 
of reduced peripheral resistance (decreased MAP). It is also noteworthy that, at these relatively 
low work intensities, we find no evidence of diminished ability to sustain the required CO or 
failure of oxygen delivery to the muscles. In Study II, we found that despite the extreme 
physiological load (i.e., high total energy expenditure) of 53-h ultra-endurance exercise, both 
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the work performed by the heart (CW) and the oxygen consumption of this organ (as indicated 
by the rate pressure product – RPP) during standardised sub-maximal cycling were attenuated. 
This could be interpreted as cardiac fatigue (Saltin and Stenberg, 1964; Douglas et al., 1987; 
Whyte et al., 2000; Dawson et al., 2005; Ashley et al., 2006) but since CO was maintained, or 
slightly increased, we interpret this change as physiologically appropriate adjustment and a 
sign of higher work efficiency. 
 
5.2.1 Cardiac size 
In short, in our investigations the hearts (LV) of adventure-racing athletes, although enlarged, 
were within normal limits.  
 
However, the only other report on adventure racers presented a pooled value for the LV mass 
of men and women that was considerably larger (323 g) (Ashley et al., 2006). There is no 
reason to believe that such a large difference between these two similar study populations of 
intermediate-to-world class athletes actually exists. Rather, this discrepancy might reflect the 
calculation employed: here, we calculated as recommended in the ASE statement from 2005 
(Lang et al., 2005), whereas in the investigation of Ashley et al. (2006) an older method of 
calculation that overestimates LV mass by approximately 20% may have been used (Devereux 
et al., 1986). With such an adjustment, the values from these two studies would be equivalent. 
 
5.2.2 Cardiac biomarkers 
Concerning the different biomarkers, our results are in line with previous studies and 
knowledge. However, circulating levels of troponin increased to exceed the reference value only 
in three participants (20%). These participants did not rate their performance lower, and did not 
appear to be more affected by cardiac fatigue, than the other participants. This finding is in line 
with Scharhag and colleagues (2005) who found no evidence of a causal link between exercise-
induced increases in cardiac troponins and myocardial damage, and suggested that the increases 
may represent a physiologic reaction under certain exercise conditions and lack pathological 
significance in healthy athletes. Consequently, we conclude that troponin release is not an 
appropriate indicator for evaluating exercise-induced cardiac fatigue. It has also been shown that 
the increases in troponin and NT-proBNP are not interrelated (Scharhag et al., 2005). The 
present study supports those findings; we could also demonstrate a lack of correlation between 
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elevations in NT-proBNP and CK-MB. The increase in the CK-MB fraction during this type of 
exercise can probably be attributed to activity in skeletal muscle, as previously shown for 
marathon runners (Apple et al., 1985; 1987). Hence, our results suggest that neither troponins 
nor CK-MB can be used as an indicator for evaluation of cardiac strain or exercise-induced 
cardiac fatigue in healthy subjects. 
 
However, measurements of BNP and NT-proBNP might still be valuable for detection and 
quantification of the level of cardiac strain, and possibly also cardiac fatigue. Despite differences 
in the half-life of BNP (20 min) versus NT-proBNP (120 min) the correlation between levels in 
plasma at Post-Ex is very strong (R2 = 0.95). It should be noted that the ultra-long duration of 
the exercise appears to make the clinical cut-off values for the biomarker with the longer half-
life, NT-proBNP, inappropriate in the ultra-endurance exercise setting. Cut-off values should 
therefore be adjusted before plasma levels are interpreted in order to give relevant information of 
the actual cardiac strain and fatigue. After the ultra-endurance exercise (at Post-Ex) the cut-off 
point for BNP at 100 ng · l-1 corresponds to 1400 ng · l-1 NT-proBNP, which is almost five times 
the clinically used cut-off point (300 ng · l-1 for NT-proBNP). Note that the relation between 
circulating levels of BNP and NT-proBNP, and thus the relevant cut-off point for NT-proBNP, 
will most likely change depending on exercise duration. Because of its more stable nature, most 
exercise studies only give values for NT-proBNP, and might therefore overestimate the 
“negative effect” of endurance exercise on the heart. In the present study seven of fifteen 
participants had levels of NT-proBNP exceeding 300 ng · l-1, but only one subject had values of 
BNP >100 ng · l-1 and NT-proBNP >1400 ng · l-1. In line with the hypothesis of a link between 
cardiac fatigue and high levels of the biomarkers, the only high responding subject’s 
performance was rated “3 – poor/weak”. It should be mentioned that we cannot determine if the 
increase in biomarkers and the decrease in performance are interdependent, or two independent 
processes occurring simultaneously. 
 
5.2.3 Rated relative performance 
The aim was also to relate the increase in cardiac biomarkers to performance. At Post-Ex seven 
participants had NT-proBNP below the clinically used reference value (<100 ng · l-1). The 
pooled rated performance for four of them was 1, and the remaining three were rated 2. At the 
other end of the spectrum, three participants had markedly higher levels than previously reported 
(>900 ng · l-1) and their performance was rated 3, 3 and 2 (Figure 16).  
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Figure 16: Comparison between NT-proBNP and rated relative performance. 
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The subjects were divided in three groups based on levels of NT-proBNP after a 5-7-day 
adventure race. Rating of relative exercise performance was conducted using a three-
grade-scale where 1 = good, strong, carried extra weight, helped/pulled teammate, 2 = 
intermediate, took care of oneself, 3 = poor, weak, took help from teammate(s). 
 
In congruence with previous observations by Sahlén and colleagues (2009) the baseline value of 
NT-proBNP was a good predictor of post-race value, even though the baseline value was well 
below the reference value (<100 ng · l-1) (Figure 17). 
 
Figure 17: Comparison between NT-proBNP before and after a 5-7-day adventure race. 
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The subjects were divided in three groups based on levels of NT-proBNP after a 5-7-day 
adventure race. 
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5.2.4 Echocardiography  
As mentioned in the Introduction, several other investigations have documented reductions in 
EF following (ultra)endurance exercise and the clinical prognostic value of a low EF is well 
recognised (e.g., the risk of death is elevated with an EF <35.5%) (Schwartz et al., 1984). In 
Study IV, however, compared to baseline value, EF was enhanced both after exercise and 
recovery. An early report (Douglas et al., 1987) showed decreased left ventricular diameter 
(LVd) following prolonged exercise, which could be interpreted as decreased preload, which 
correlates strongly with reduced EF. In studies where the preload has been kept stable, EF has 
also been maintained (Hassan et al., 2006). In the present case LVd was consistent at all time-
points of measurement, which might have contributed to the increase in EF. Unfortunately, the 
limitations involved in calculating SV or CO from echocardiographic data do not allow us to 
present these values in the Results. Although no definitive conclusions can be drawn our 
findings do suggest that both SV and CO were maintained (and, indeed, that CO was slightly 
increased after both exercise and recovery). If CO is maintained, the metabolic demand is most 
likely being met, an obvious goal that should not be difficult to achieve when the body is at rest. 
CO is, of course, the product of HR times SV and in the present study HR was increased, 
possibly due to an elevated sympathetic drive, since high circulating levels of catecholamines 
after 24 h of continuous exercise have been observed (Study I). It has been proposed that 
increased HR is the primary change in the progression of normal cardiovascular drift (Fritzsche 
et al., 1999; Coyle and Gonzalez-Alonso, 2001), the decreases in SV and EF being secondary 
consequences and, thereby, doubtful indicators of cardiac fatigue. 
 
In agreement with previous findings, the E/A of our subjects was reduced both after exercise 
and recovery in comparison to the baseline. This complex finding is difficult to interpret, but is 
considered to indicate impairment of myocardial relaxation. In our case E was maintained and 
the ratio decreased primarily due to an elevation in A. This preservation of E is in line with the 
sustained preload (LVd) discussed above. The elevation in A is, to some extent, a consequence 
of the shortened diastole associated with increased HR. Therefore, the decrease in E/A could 
be an adaptation to the increase in HR (from 50 bpm at baseline to 58 bpm after the exercise). 
However, despite this theoretical reasoning, a meta-analysis found no correlation between 
alterations in HR and E/A (Middleton et al., 2006). 
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5.2.5 Tissue velocity imaging 
The major focus in Study IV was on peak myocardial velocities. First of all, our participants 
exhibited normal values for all of the parameters concerning myocardial velocities assessed. 
Furthermore, there were no indications of any decrement in peak systolic velocities in any 
myocardial segment following ultra-endurance exercise. On the contrary, either after exercise 
and/or following recovery, these velocities were significantly elevated in two of the three walls 
measured (i.e., the left lateral, septal and right ventricular free walls). Although it might have 
been physiologically interesting to also make our measurements during the exercise itself, it has 
been shown previously that a damaged heart demonstrates impaired contraction velocities even 
at rest (Pasquet et al., 1999). 
 
The decrements in IVR and IVC durations in both the left and right ventricles are primarily a 
consequence of the enhanced HR. Prolonged IVR would be indicative of an impairment of LV 
function (Betocchi et al., 1986; Leung et al., 1990). The only parameter in present study that 
could indicate decreased cardiac function is the increased incidence of measurable right 
ventricular IVR duration. The duration of right ventricular IVR is determined by systolic 
pulmonary artery pressure which when raised, delays the opening of tricuspid valves and 
proportionately prolongs the duration of IVR (Burstin, 1967; Lindqvist et al., 2006).  
 
5.3 METHODOLOGICAL CONSIDERATIONS AND LIMITATIONS 
5.3.1 Points of measurements during exercise 
A common limitation of cardiovascular research on ultra-endurance exercise is that it is almost 
exclusively performed during competitions. Even when HR is recorded continuously during 
competition, the drift in combination with the changes in work intensity throughout the races 
poses a problem. When reported, both HR and speed decrease from the start to the end of the 
race (Cottin et al., 2007; Neumayr et al., 2003). A major strength in present work is that Study I 
and II (first half) was performed as simulated races in a laboratory setting, enabling for 
controlled work intensity and multiple measurements of VO2, blood sampling and other 
parameters during standardised work rates possible. In addition, the control of energy intake in 
the 24-h protocol was rigorous, with similar relative energy intake and composition for all 
subjects. Thanks to the kind and enduring athletes and the great support from the race organisers, 
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we could collect data for the second half of Study II as well as Study III and IV even during 
actual competitions. 
 
5.3.2 Exercise intensity controlled using HR-monitor  
It can be considered somewhat of a paradox to use HR-values to control intensity in the 12- and 
24-h protocols since one of the aims was to investigate cardiovascular drift. It would have been 
possible to ensure a fixed work rate throughout the protocol by setting the exercise ergometers to 
a resistance equivalent to 60% VO2peak using data collected during the pre-tests. First of all, this 
was not entirely possible since the athletes partly exercised outdoor. Mainly, it should be noticed 
that no similar studies had been carried out before present ones, hence making it impossible to 
know if the participants would be able to keep a constant workload equivalent to 60% VO2peak 
for 24 h. Heart rate curves, on the other hand, were retrieved from previous competitions. 
 
5.3.3 Circadian rhythm  
Since study I was performed during a full day and night and study III and IV were carried out 
during the course of several days another aspect to consider is the normal circadian rhythm. 
Obviously, many bodily functions, such as hormonal status, are affected over the course of day 
and night. One parameter affected is HR. During continuous measurements of HR at bed rest 
minimum values were found between 4-5 am and maximum between 11-12 am. The 
difference between highest and lowest HR was approximately 6 beats • min-1 (Kräuchi and 
Wirz-Justice, 1994). Wahlberg and Åstrand (1973) stated that HR during both submaximal 
and maximal exercise was 3-5 beats • min-1 lower at night (3 am) compared to day (3 pm). The 
circadian rhythm is also preserved during a 24-h continuous walking race (Cottin et al., 2007). 
In study I the three groups of subjects began exercise at 10:00, 11:50 and 13:40. The starting 
times coincide with the maximum level of the circadian HR curve and the minimum should 
appear after 14 to 18 h of exercise, after which a re-increase is expected. As seen in Figure 12 
this is evidently not the case. HR at 14 to 18 h is lower than at 2 to 8 h, but still higher than 
initial levels. No increase was then present during the last six hours. Even though circadian 
rhythm may partially explain changes in HR at fixed work rate the extent of the HR drift in 
Study I is at least double the amount suggested. In Study II the decrease in HR below initial 
values at the end of the 53 h event might be explained in part by normal circadian rhythm 
related changes in HR, since most of these measurements were conducted at night. However, 
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since CO was maintained at a stable level the decreased HR might be driven by an increase in 
SV, which is facilitated by decreased peripheral resistance (TPR and MAP).  
 
Another aspect to address is the sleep deprivation that this set-up induces. Even though sleep-
loss influences physiological effects, such as increased perceived exertion and reduced time to 
exhaustion during heavy exercise, the HR and metabolic parameters relevant for this study 
remain unchanged (Martin, 1981; Martin and Gadis, 1981). 
 
5.3.4 Race situation, climate and subjects  
There are several confounding factors in this type of field protocols in race settings (Study II-IV) 
that potentially could have an impact on circulatory parameters. For that reason comparisons in 
Study II between the 12-h protocol (controlled intensity) and the 53-h protocol (race) are limited 
by the fact that they are different in character and were performed by different individuals. An 
obvious limitation is the use of non-invasive methods, and furthermore the calculated estimates 
of cardiac parameters. Unfortunately, it is not possible to conduct more invasive measurements 
in a safe and ethical way during this type of exercise. A major limitation is that energy intake, 
electrolyte intake and status, and water intake was not controlled for. However, Hct levels were 
stable throughout both protocols indicating stable fluid status. Another factor that might 
influence the results is the actual race. It can be considered a limitation that both race-protocols 
were held in normal Nordic summer climate, and that all subjects were Scandinavian. We cannot 
with certainty claim whether a similar race, but with different set-up (stages duration and order), 
time for rest, and ambient temperature would not induce different results.  
 
5.4 FUTURE PERSPECTIVES 
Study IV, as well as all previous studies concerning exercise-induced cardiac fatigue, involved 
monitoring subjects at rest prior to and after exercise. However, peak systolic velocities 
associated with maximal or near-maximal HR would provide a more accurate indicator of 
cardiac fatigue. Although a promising procedure for measuring TVI has recently been developed 
(Carlsson et al., in press), it is still difficult for subjects to achieve maximal HR following ultra-
endurance exercise, due to general fatigue. Nonetheless, future studies concerning cardiac 
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fatigue would most likely benefit from measuring contraction velocities at higher (preferably 
maximal) work- and heart rate. 
 
Since we suggest that intensity, and not duration, is the main determinant of cardiac fatigue an 
investigation designed to properly address this matter would be interesting and desirable. Such a 
study should ideally involve the same subjects performing exercise protocols of several different 
durations, e.g., 3 h, 6 h, 12 h and 48 h, and each exercise duration protocol should be performed 
at several different relative intensities, e.g., 40, 60 and 80 % of VO2peak. Since it most likely will 
be impossible to exercise e.g., at 80 % of VO2peak for 48 h, some protocol might be performed 
until exhaustion. 
 
We did not find a single athlete with pathologically increased cardiac size. However, a long term 
follow-up (5 and/or 10 years) of both myocardial size and function in the athletes examined in 
Study IV would be valuable. Furthermore, a cross-sectional study using MRI to examine 
possible damage and scarring in athletes who have been training and competing in ultra-
endurance events for more than 10 or 15 years would illuminate long term risks.  
 
The first studies we conducted were simply descriptive in its nature, and we then transcended to 
studies aiming for a more explanatory angle. An obvious and desirable progress for future 
investigations would be intervention studies.  
 
5.5 PERSONAL REFLECTIONS 
As a (former) adventure racer and a scientific researcher I find it encouraging that we, during the 
five+ years of the project, have been able to scientifically prove many of the physiological 
reactions and adaptations that the athletes had noticed empirically. The fundamental idea leading 
up to the project was that adventure racing exposes the human organism to a unique situation, 
and that the successful adventure racer is a distinctive breed of athlete. If that should be true, 
traditional textbook knowledge of physiological adaptations and exercise training might not be 
fully applicable. Another concern was whether this type of exercise had serious detrimental 
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effects. This question that was unanswered and debated since research was sparse and empirical 
long-term follow-up not performed due to newness of the sport.  
 
Summing up the project it feels safe to conclude that this exercise and athletes are somewhat 
unique. An example of something the athletes had felt was the difficulty to reach high HR after 
some hours of exercise. We showed that the reversed cardiovascular drift plays a part in this, 
associated with desensitisation of the heart’s adrenergic receptors, shown by other investigators. 
There are apparently many aspects of the optimal training and competition strategies. We have 
illuminated that energy intake is important, and that eating and drinking (and be able to keep it) 
could be a required skill. The studies on mitochondria indicate specific adaptations, including 
increased maximal oxidation of fat. For this adaptation to occur, it is likely that athletes need to 
exercise continuously for many hours, which is not conventional in the training situation but is 
self-evident during adventure racing competition. Obviously, there are many reasons why 
experience is important for winning races. However, the physiological adaptations to repetitive 
ultra-endurance exercise may be crucial. For instance all athletes in the top-2 teams of ARWC 
2006 were older than 30 years, and two out of four in the winning team was older than 40 years. 
The vast majority of the Swedish top-athletes of today have been competing for many years. 
Concurrently, the speed in the races has increased dramatically. For example, in the early races 
450 km was completed in 5-6 days, but in the ARWC 2006 more than 800 km was covered in 
just over 5 days! Still, the athletes that have performed this evolving journey of the sport used to 
be specialists in one exercise discipline who then transcended to adventure racing. It will be 
interesting to see if the speed in the competitions will continue to increase with the next 
generation of athletes who specialize in adventure racing from an early age. An important 
observation from present thesis is that this type of exercise does not seem to have detrimental 
effects on the heart. Still, our present and future findings might be useful in clinical cardiology, 
especially concerning recovery. The athletes display rapid reversal in e.g., biomarkers, whereas 
patients have a much slower kinetics. Even though the duration is extreme the risks does not 
seem to be higher than for other endurance events, such as marathon, pointing towards intensity 
as the primary determinant of cardiac fatigue and possible damage. This idea might be true also 
for other injury aspects. Several investigators have demonstrated high incidence of pain and 
injury during and after ARs. However, the athletes seem to be less injured during training than 
specialists in other endurance sports. A possible reason is that adventure racers, due to the many 
different exercise modes, can chose to put strain on different parts of the body, and consequently 
rest other parts, and still get full desired training effect. 
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6 CONCLUSIONS 
 
• The sizes of the hearts (LV) of all of our ultra-endurance athletes were within normal 
limits.  
• The central circulation changes in several steps in response to ultra-endurance exercise. 
Drifts over time occur in most of the measured parameters. 
o HR at fixed submaximal work rate increase only during the first six hours of 
exercise, after which HR gradually decreases towards initial values. 
o Compared to initial levels, VO2 is increased at every time-point (5-15%). The 
increase can be attributed to peripheral adaptations, confirmed by a close 
correlation between change in VO2 and change in a-v O2 diff.  
o Upward drift of HR and VO2 resulted in an increased oxygen pulse (VO2/HR) 
after the first six hours of exercise, and the calculated amount of oxygen 
extracted from each heart beat increase by approximately 10% (indicating a more 
efficient energy distribution).  
o When exercise continues for 50 h late cardiovascular drift can be observed, 
characterised by increased VO2/HR, decreased peripheral resistance, increased 
stroke volume, and decreased work of the heart. Since cardiac output is 
maintained we interpret the changes as physiologically appropriate adaptations to 
ultra-endurance exercise.  
• Increased levels of troponin and CK-MB seem to lack relevance in the (healthy) exercise 
setting, but that BNP, or NT-proBNP adjusted for exercise duration, might be a relevant 
indicator for impairment of exercise performance.  
• Levels of NT-proBNP up to 2500 ng · l-1 can be present after ultra-endurance exercise in 
healthy athletes without any subjective signs or clinical symptoms of heart failure. High 
levels of NT-proBNP seem to be associated with decreased relative exercise 
performance, and might be an indicator of the cardiac fatigue. 
• Measurements of peak systolic velocities at rest showed no signs of cardiac fatigue in 
our ultra-endurance athletes even after 6 days of continuous exercise.  
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7 SAMMANFATTNING (SUMMARY IN SWEDISH) 
Den övergripande målsättningen med denna avhandling är att redogöra för hur den centrala 
cirkulationen påverkas av ultra-uthållighetsarbete (multisport/Adventure Racing), samt bidra till 
kartläggningen av den så kallade "arbetsinducerade hjärtutmattningen". 
Ett Adventure Race (AR) varierar i längd från 6 timmar till över 6 dagar. Deltagarna ska 
navigera via ett antal kontrollstationer över en förbestämd sträcka, och utföra en kombination av 
tre eller flera uthållighetsidrotter, t.ex. cykling, löpning och kajakpaddling. Denna avhandling är 
baserad på resultaten från fyra olika försöksprotokoll, 12- och 24-tim (n = 8 och 9, respektive) 
i en kontrollerad miljö och arbetsintensitet och 53-tim och 5-7-dagar (n = 15 i vardera) i 
tävlingssituation. Försökspersonerna i samtliga delarbeten var erfarna elitaktiva 
multisportatleter. Studie I och II behandlar den cirkulatoriska responsen under ergometer 
cykling på fasta arbetsbelastningar under perioder före, under och efter ultra-uthållighetsarbete 
Mätningarna innefattade hjärtfrekvens (HR), syreupptagning (VO2), blodtryck och 
hjärtminutvolym (icke-invasiv återandning). I studie III och IV undersökte vi eventuell 
förekomst av arbetsinducerad hjärtutmattning efter ett 5-7-dagars AR, från två olika perspektiv. I 
studie III användes biokemiska metoder för att bestämma plasmanivåer av hjärtspecifika 
biomarkörer (dvs. kreatinkinas isoenzym MB (CK-MB), troponin, B-typ natriuretisk peptid 
(BNP) och N-terminal prohormonal B-typ natriuretisk peptid (NT-proBNP)). Vi relaterade även 
ökningar av biomarkörer med skattad relativ prestation. I studie IV användes mätningar av 
hjärtats kontraktionshastigheter (TVI) (VIVID I, GE VingMed Ultraljud, Norge) för se 
funktionella tecken på hjärtutmattning, dvs. sänkta topphastigheter på kontraktionen. Med 
konventionell ekokardiografi utvärderades om dessa atleters hjärtan var större än den normala 
övre gränsen.  
Den centrala cirkulationen förändras i flera steg som svar på ultra-uthållighetsarbete. 
Jämfört med initialnivåerna var VO2 förhöjd vid samtliga mättillfällen. Ökningen kan tillskrivas 
perifera anpassningar, vilket bekräftas av ett nära samband mellan förändringar i VO2 och 
förändring i arterio-venös syreextraktion. Det första steget i det cirkulatoriska svaret var den 
typiska (tidiga) driften med ökning i HR och samtidigt minskande slagvolym (SV) och syrepuls 
(VO2/HR), som fortgår under de första 4-6 timmarna. Det andra steget, som fortgick till ca 12 
tim, innebar omvänd HR-drift, med normalisering av SV och VO2/HR. När arbetet pågick upp 
till 50 tim noterades en ”sen” kardiovaskulär drift, som kännetecknades av ökad VO2/HR, (vilket 
indikerar effektivare energidistribution), minskad perifer resistens, ökad SV, och minska 
mekaniskt arbete i hjärtat. Eftersom hjärtminutvolymen hela tiden bibehölls så vi tolkar 
förändringarna som fysiologiskt adekvata anpassningar.  
Resultaten från studie III pekar mot en åtskillnad mellan den patologiska och den 
fysiologiska frisättningen av hjärtspecifika biomarkörer. Resultaten tyder på att troponin och 
CK-MB saknar relevans, men att BNP, och NT-proBNP justerat för arbetstid, kan vara en 
relevant tecken för försämrad arbetsförmåga. Höga nivåer av NT-proBNP, upp till 2500 ng • L-
1
, kan förekomma efter ultra-uthållighetsarbete hos friska idrottare utan några kliniska symtom 
på hjärtsvikt. Dock verkade höga nivåer av NT-proBNP vara relaterat till försämrad relativ 
arbetsförmåga och en indikator på hjärtutmattning. Studie IV visade att storleken på ultra-
uthållighetsidrottarnas hjärtan (vänster kammare) var inom normala gränser. Mätningarna av 
maximala kontraktionshastigheter visade (för gruppgenomsnitt) inga tecken på hjärtutmattning, 
ens efter 6 dygn av kontinuerligt arbete. Skillnaden mellan våra och andras fynd, skulle kunna 
bero på det faktum att denna typ av arbete utförs med relativt låg genomsnittlig intensitet, vilket 
tyder på att intensiteten, snarare än varaktighet, är den viktigaste faktorn för hjärtutmattning. 
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